연구동향
기준 논문: Inflammatory Cytokines and Cognition in Alzheimer's Disease and Its Prodrome
이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.
3,285편 검색→1,972편 판독→1360편 선별 (관련도 0.5 이상)
질문과 PubMed 검색식 보기
질문: Inflammatory cytokines such as interleukin-6 and tumor necrosis factor and cognition in Alzheimer disease and mild cognitive impairment
(("interleukin-6"[tiab] OR "interleukin 6"[tiab] OR IL-6[tiab] OR "tumor necrosis factor"[tiab] OR TNF[tiab] OR "TNF-alpha"[tiab] OR "inflammatory cytokine*"[tiab]) AND (cognition[tiab] OR cognitive[tiab] OR cognitive function[tiab] OR "cognitive decline"[tiab] OR memory[tiab]) AND ("Alzheimer disease"[tiab] OR "Alzheimer's disease"[tiab] OR "Alzheimer*"[tiab] OR "mild cognitive impairment"[tiab] OR MCI[tiab]))출판 연도
선별된 1360편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.
주제별 논문
주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.
01rats · oxidative stress332편
- 0.91
Lu Q, Meng Y, Feng H et al. · Current issues in molecular biology · 2025
- 0.87
Siddiqui N, Ali J, Parvez S et al. · Neurochemical research · 2023
- 0.86
Arora R, Deshmukh R · Molecular neurobiology · 2025
- 0.86
Yan T, Liu B, Wang N et al. · Experimental gerontology · 2021
- 0.86
Gurram PC, Manandhar S, Satarker S et al. · Neuropeptides · 2025
- 0.86
Cam Ozunlu SA, Uysal F, Tatli Dogan H et al. · Brain research · 2025
- 0.85
More SA, Sikkalgar A, Chourasiya N et al. · Computers in biology and medicine · 2026
- 0.85
Naik S, Katariya R, Shelke S et al. · European journal of pharmacology · 2023
- 0.85
Nillert N, Boonyarat C, Welbat JU et al. · BMC complementary medicine and therapies · 2022
- 0.85
Kewal A, Rajput MS, Shah J et al. · Inflammopharmacology · 2026
- 0.85
Hawiset T, Sriraksa N, Anukanon S et al. · Advances in pharmacological and pharmaceutical sciences · 2025
- 0.85
Kolaviron neuroprotective effect against okadaic acid-provoked cognitive impairment
Nazari-Serenjeh M, Baluchnejadmojarad T, Hatami-Morassa M et al. · Heliyon · 2024
- 0.84
Movaffagh S, Behzadifard M, Moghaddasi M et al. · Metabolic brain disease · 2026
- 0.84
Ahsan R, Khan MM, Mishra A et al. · Brain research · 2025
- 0.84
Improvement of cognitive deficit of curcumin on scopolamine-induced Alzheimer's disease models
Cakmak G, Kaplan DS, Yildirim C et al. · Caspian journal of internal medicine · 2022
- 0.84
Gurkan G, Akdag B, Erdogan MA et al. · Journal of Korean Neurosurgical Society · 2026
- 0.84
Nikkar R, Esmaeili-Bandboni A, Badrikoohi M et al. · Metabolic brain disease · 2022
- 0.84
Toledano RS, Akirav I · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
- 0.83
Amin H, Bukhari SA, Chauhdary Z et al. · PloS one · 2025
- 0.83
Ledezma C, Coria-Lucero C, Castro A et al. · Neurochemistry international · 2022
- 0.83
Siddiqui N, Ali J, Parvez S et al. · Neuropharmacology · 2021
- 0.83
Liu S, Yan J, Dong J · Frontiers in pharmacology · 2025
- 0.83
Celastrol Attenuates Learning and Memory Deficits in an Alzheimer's Disease Rat Model
Xiao Y, Wang X, Wang S et al. · BioMed research international · 2021
- 0.83
Verma V, Singh D, Kh R · Brain sciences · 2020
- 0.83
Liu H, Zhong L, Dai Q et al. · Neuroimmunomodulation · 2022
- 0.83
Couly S, Denus M, Bouchet M et al. · The international journal of neuropsychopharmacology · 2021
- 0.83
Abdel-Salam OM, El-Shamarka MES, Youness ER et al. · Iranian journal of basic medical sciences · 2021
- 0.82
Heydari R, Khosravifar M, Abiri S et al. · Behavioural brain research · 2025
- 0.82
Agarwal M, Singhal M, Basist P et al. · Recent advances in food, nutrition & agriculture · 2025
- 0.82
Khozani MS, Palizvan M, Mosayebi G et al. · Inflammopharmacology · 2026
- 0.82
Nekabari MK, Ben-Azu B, Chijioke BS et al. · Neurotoxicity research · 2026
- 0.82
Abu-Elfotuh K, Al-Najjar AH, Mohammed AA et al. · International immunopharmacology · 2022
- 0.82
Bhardwaj S, Jindal A, Singh S et al. · Assay and drug development technologies · 2025
- 0.82
Ed-Day S, Kacimi FE, El Gui R et al. · Molecular biology reports · 2026
- 0.82
Soni U, Pujari R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- 0.82
The protective role of melatonin on the brain in a rat model of Alzheimer's disease
Mostafa SS, Mohammed RA, Abbas AY et al. · Metabolic brain disease · 2026
- 0.82
Gall Z, Boros B, Kelemen K et al. · Frontiers in pharmacology · 2024
- 0.82
Amin S, Qusti S, Al-Otaibi WA et al. · Neurochemical research · 2025
- 0.81
Pharmacological evaluation of bromelain in mouse model of Alzheimer's disease
Kumar R, Kumar R, Sharma N et al. · Neurotoxicology · 2022
- 0.81
Chen S, Han C, Wang X et al. · Brain research · 2024
- 0.81
Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer's disease
Alavi MS, Fanoudi S, Hosseini M et al. · Metabolic brain disease · 2022
- 0.81
Ullah R, Ali G, Ahmad N et al. · Pharmaceuticals (Basel, Switzerland) · 2020
- 0.81
Chauhan P, Wadhwa K, Singh G · Journal of ethnopharmacology · 2026
- 0.81
Teng Y, Gao J, Tan T et al. · Journal of chemical neuroanatomy · 2024
- 0.81
Khan WU, Salman M, Ali M et al. · Neurochemistry international · 2024
- 0.81
Yamini P, Ray RS, Yadav S et al. · Pharmacology, biochemistry, and behavior · 2022
- 0.81
Diddi S, Lohidasan S, Arulmozhi S et al. · Journal of ethnopharmacology · 2023
- 0.81
Assi AA, Farrag MMY, Badary DM et al. · Inflammopharmacology · 2023
- 0.81
Minhas AM, Khan AU, Gul Qazi N et al. · Iranian journal of basic medical sciences · 2026
- 0.81
Babaei H, Kheirollah A, Ranjbaran M et al. · Biochemical and biophysical research communications · 2023
- 0.81
Cao F, Xu L, He X et al. · Archives of medical science : AMS · 2025
- 0.81
Abd Elmonem HA, Morsi RM, Mansour DS et al. · Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2023
- 0.81
Neuroprotective Effects of Amifostine in Mouse Model of Alzheimer's Disease
Alwaeli NLW, Al-Zubaidy AAK · Clinical laboratory · 2024
- 0.81
de Mello JE, Teixeira FC, Dos Santos A et al. · Molecular neurobiology · 2024
- 0.81
Dhami M, Raj K, Singh S · Current Alzheimer research · 2021
- 0.81
Liu YC, Chen SY, Chen YY et al. · International journal of biological macromolecules · 2024
- 0.80
Chauhan P, Wadhwa K, Singh G · Inflammopharmacology · 2026
- 0.80
Ameliorative effect of myrcene in mouse model of Alzheimer's disease
Kumar R, Kumar R, Sharma N et al. · European journal of pharmacology · 2021
- 0.80
Song X, Zhao Z, Zhao Y et al. · Journal of microbiology and biotechnology · 2022
- 0.80
Marschner RA, Ribeiro RT, Gayger-Dias V et al. · Scientific reports · 2026
- 0.80
Liu L, Jiang M, Zhang Y et al. · Brain research · 2025
- 0.80
Saleem U, Hira S, Anwar F et al. · Frontiers in pharmacology · 2021
- 0.80
Rathod SS, Agrawal YO · The European journal of neuroscience · 2025
- 0.80
Kadian M, Saini N, Khera A et al. · Inflammopharmacology · 2024
- 0.80
Nafea M, Elharoun M, Abd-Alhaseeb MM et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2023
- 0.80
Sepulveda P, Ferreira AFF, Sandoval C et al. · Cells · 2024
- 0.80
Wu X, Qiu X, Wang S et al. · Journal of ethnopharmacology · 2025
- 0.80
Tayanloo-Beik A, Kiasalari Z, Roghani M · Journal of molecular neuroscience : MN · 2022
- 0.80
Ayobami FG, Ogundipe OJ, Emmanuel AA et al. · Nutritional neuroscience · 2025
- 0.80
Kanika, Singh L · Molecular biology reports · 2024
- 0.80
Talib M, Siddiqui N, Tripathi PN et al. · Neurochemical research · 2025
- 0.80
Khani-Robati A, Banizaman M, Jahromi F et al. · 3 Biotech · 2026
- 0.80
Akbarizadeh-Mashkani MH, Afshinmajd S, Iranzadeh S et al. · Avicenna journal of phytomedicine · 2025
- 0.80
Ma S, Xu CC, Dong YC et al. · Combinatorial chemistry & high throughput screening · 2025
- 0.80
Tsai HY, Qiu J, Liao HW et al. · International journal of molecular sciences · 2026
- 0.80
Ali J, Khan A, Park JS et al. · Nutrients · 2023
- 0.80
Alharbi KM, Alshehri SA, Almarwani WA et al. · Current Alzheimer research · 2024
- 0.80
Goswami P, Akhter J, Mangla A et al. · Molecular neurobiology · 2024
- 0.79
Kazemi M, Esmaeili-Mahani S, Abbasnejad M et al. · Behavioural brain research · 2025
- 0.79
Mohammadi N, Asle-Rousta M, Rahnema M et al. · European journal of pharmacology · 2021
- 0.79
Nasr NN, El-Hagrassi AM, Ahmed YR et al. · Chemistry & biodiversity · 2025
- 0.79
Zhang Z, Wu H, Qi S et al. · International journal of environmental research and public health · 2022
- 0.79
Maheta P, Patel C, Parmar D et al. · ACS chemical neuroscience · 2025
- 0.79
Rajkumar M, Kannan S, Thangaraj R · Inflammopharmacology · 2023
- 0.79
Avicularin Attenuates Memory Impairment in Rats with Amyloid Beta-Induced Alzheimer's Disease
Samant NP, Gupta GL · Neurotoxicity research · 2022
- 0.79
Guin S, Jangli A, Dandekar MP · International immunopharmacology · 2026
- 0.79
Ahmad W, Choe K, Ahmad R et al. · Frontiers in aging neuroscience · 2025
- 0.79
Badrikoohi M, Esmaeili-Bandboni A, Babaei P · Brain research bulletin · 2022
- 0.79
Sani SSM, Eidi A, Rajabian A et al. · Molecular neurobiology · 2025
- 0.79
Mohammadi F, Koohi MK, Adeli S et al. · Scientific reports · 2026
- 0.79
Kazmi I, Afzal M, Imam F et al. · ACS omega · 2024
- 0.79
Younas S, Badshah I, Akbar K et al. · Current neuropharmacology · 2026
- 0.79
Akgol J, Kutlay O, Keskin Aktan A et al. · Current issues in molecular biology · 2024
- 0.78
Jayaswamy PK, Ambrish T, Sangamesh VC et al. · Ecotoxicology and environmental safety · 2026
- 0.78
Ghoneum MH, El Sayed NS · Oxidative medicine and cellular longevity · 2021
- 0.78
Ensandoust T, Khakpour-Taleghani B, Jafari A et al. · Behavioural brain research · 2025
- 0.78
Yildirim C, Cevik S, Bal R et al. · Molecular neurobiology · 2026
- 0.78
Vicente MC, Paneghini JL, Stabile AM et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.78
Rajkumar M, Navaneethakrishnan S, Muthukumar S et al. · Journal of chemical neuroanatomy · 2023
- 0.78
Beltagy DM, Nawar NF, Mohamed TM et al. · Prostaglandins & other lipid mediators · 2024
- 0.78
Hasan N, Zameer S, Najmi AK et al. · Pharmacological reports : PR · 2021
- 0.78
Abdallah HM, El Sayed NS, Sirwi A et al. · Biology · 2021
- 0.78
Hall TK, Paim MP, da Costa P et al. · ACS chemical neuroscience · 2025
- 0.77
- 0.77
Gomaa AA, Farghaly HSM, Ahmed AM et al. · International immunopharmacology · 2023
- 0.77
Neuroprotective effects of ononin against the aluminium chloride-induced Alzheimer's disease in rats
Chen X, Zhang M, Ahmed M et al. · Saudi journal of biological sciences · 2021
- 0.77
Oyeleke MB, Owoyele BV · Journal of ethnopharmacology · 2022
- 0.77
Awwad ZM · Inflammopharmacology · 2026
- 0.77
Xu Z, Zhu Y, Liu L et al. · Metabolic brain disease · 2025
- 0.77
Razzaq R, Ahmed T, Butt AM et al. · Biochemical and biophysical research communications · 2026
- 0.77
Acanthopanax Senticosus Saponins Prevent Cognitive Decline in Rats with Alzheimer's Disease
Cui XM, Wang W, Yang L et al. · International journal of molecular sciences · 2025
- 0.77
Chen CY, Tsai TY, Chen BH · Antioxidants (Basel, Switzerland) · 2021
- 0.77
Patel R, Kaur K, Singh S · Inflammopharmacology · 2021
- 0.76
Widyastuti K, Mahadewa TGB, Suprapta DN et al. · Dementia & neuropsychologia · 2022
- 0.76
Abd El-Rady NM, Ahmed A, Abdel-Rady MM et al. · Physiological reports · 2021
- 0.76
Shanehbandpour-Tabari F, Golchoobian R, Pourabdolhossein F · European journal of pharmacology · 2026
- 0.76
Bavafa A, Meftahi GH, Pirzad Jahromi G · Neurochemical research · 2025
- 0.76
Verma N, Gupta JK, Varshney KK et al. · Drug metabolism letters · 2021
- 0.76
Piekarczyk N, Berezka P, Majkutewicz I et al. · Free radical biology & medicine · 2025
- 0.76
Cakir M, Yuksel F, Mustafa Ozkut M et al. · International immunopharmacology · 2023
- 0.76
Arjmandi-Rad S, Zarrindast MR, Shadfar S et al. · Experimental brain research · 2022
- 0.76
Chik MW, Meor Mohd Affandi MMR, Mohd Nor Hazalin NA et al. · Metabolic brain disease · 2025
- 0.76
Aboulhoda BE, Rashed LA, Ahmed H et al. · Journal of cellular physiology · 2021
- 0.75
Zeng T, Zhang C, Sun L et al. · Cell biochemistry and biophysics · 2025
- 0.75
Hosseini MS, Saheli M, RajiZadeh MA et al. · Biochemical and biophysical research communications · 2026
- 0.75
Khan-Mohammadi-Khorrami MK, Asle-Rousta M, Rahnema M et al. · Journal of biochemical and molecular toxicology · 2022
- 0.75
Joodi SA, Khattab MM, Ibrahim WW · Toxicology and applied pharmacology · 2025
- 0.75
Amirpour M, Mirshekar MA, Sedaghat G et al. · Nutritional neuroscience · 2022
- 0.75
Mohamed EA, Ahmed HI, Zaky HS et al. · Journal of ethnopharmacology · 2021
- 0.75
Elseweidy MM, Mahrous M, Ali SI et al. · Neurotoxicity research · 2023
- 0.75
Andrade VHBd, M Rodrigues EY, Dias NAF et al. · ACS chemical neuroscience · 2023
- 0.75
Nabil M, Kassem DH, Ali AA et al. · BioFactors (Oxford, England) · 2023
- 0.75
Khamies SM, El-Yamany MF, Ibrahim SM · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
- 0.75
Hindam MO, Ahmed LA, El Sayed NS et al. · Life sciences · 2024
- 0.75
Mohamed EA, Ahmed HI, Zaky HS et al. · Environmental science and pollution research international · 2022
- 0.75
Ayuba M, Che Mohd Nassir CMN, Abdul Hamid H et al. · Nutritional neuroscience · 2026
- 0.74
Awad SM, Attia YA, ElSayed H et al. · Journal of molecular histology · 2025
- 0.74
The involvement of neuroinflammation in an animal model of dementia and depression
Zabot GC, Medeiros EB, Macarini BMN et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2024
- 0.74
El Sayed NS, Abidar S, Nhiri M et al. · Phytotherapy research : PTR · 2023
- 0.74
Manzoor M, Iqbal MO, Dan W et al. · Journal of ethnopharmacology · 2025
- 0.74
Yang X, Jiang M, Wu M et al. · Brain research · 2025
- 0.74
Mandour DA, Bendary MA, Alsemeh AE · Journal of molecular histology · 2021
- 0.74
Tofighi N, Asle-Rousta M, Rahnema M et al. · Neurotoxicology · 2021
- 0.74
Attia MSM, Ahmad SF, Nadeem A et al. · Metabolic brain disease · 2026
- 0.74
Kaur S, Raj K, Gupta YK et al. · Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2021
- 0.74
Bagwe Parab S, Tripathi P, Barve K et al. · Metabolic brain disease · 2026
- 0.74
- 0.73
Ito T, Degawa T, Okumura N · BMC complementary medicine and therapies · 2023
- 0.73
Rapaka D, Bitra VR, Ummidi R et al. · Neuropeptides · 2021
- 0.73
Abdel-Lah ES, Hamad N, Taha AF et al. · Drug development research · 2025
- 0.73
Azzam SM, Abdel Rahman AAS, Ahmed-Farid OA et al. · International journal of biological macromolecules · 2023
- 0.73
Onasanwo SA, Adamaigbo VO, Adebayo OG et al. · Metabolic brain disease · 2021
- 0.73
Kuedo Z, Binlateh T, Benjakul S et al. · Neurochemical research · 2024
- 0.73
Jeong ES, Bajgai J, You IS et al. · International journal of molecular sciences · 2021
- 0.73
Baluchnejadmojarad T, Roghani M · Metabolic brain disease · 2024
- 0.73
Khoshnam SE, Sarkaki A, Farbood Y et al. · Neurochemical research · 2025
- 0.73
Ponce-Lopez T, Gonzalez Alvarez Tostado JA, Dias F et al. · Biomolecules · 2023
- 0.73
Rostami A, Taleahmad F, Haddadzadeh-Niri N et al. · Journal of molecular neuroscience : MN · 2022
- 0.73
Singh L, Gupta GD, Singh S · Assay and drug development technologies · 2026
- 0.73
Feng R, Chen Z, Chen L et al. · Neurotoxicology · 2025
- 0.73
Alikhanzade M, Khosravi M, Hosseini M et al. · Inflammopharmacology · 2025
- 0.73
Saini D, Mujeeb M, Akhtar M et al. · Molecular biology reports · 2026
- 0.73
Badal R, Kaur B, Singh H et al. · Brain research bulletin · 2026
- 0.73
Satarker S, Gurram PC, Nassar A et al. · Molecular neurobiology · 2024
- 0.72
Mannan A, Singh S, Mohan M et al. · Metabolic brain disease · 2025
- 0.72
Rajkumar M, Govindaraj P, Vimala K et al. · Metabolic brain disease · 2024
- 0.72
Shabbir A, Rehman K, Akash MSH et al. · Environmental science and pollution research international · 2022
- 0.72
Faldu KG, Patel SS, Shah JS · Metabolic brain disease · 2023
- 0.72
Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study
Yang Q, Kang ZH, Zhang J et al. · Cell journal · 2021
- 0.72
Multitarget pharmacological effects of Lawsone in mitigating Alzheimer's disease
Bashir MA, Ullah I, Batool GA et al. · European journal of pharmacology · 2026
- 0.72
Wu XJ, Shu QQ, Wang B et al. · American journal of Alzheimer's disease and other dementias · 2022
- 0.72
Wang Y, Deng L, Wang L et al. · European journal of pharmacology · 2025
- 0.72
Bashir DJ, Manzoor S, Sarfaraj M et al. · ACS omega · 2023
- 0.72
El-Hawary SS, Sobeh M, Badr WK et al. · Saudi journal of biological sciences · 2020
- 0.71
Kalra P, Chaturvedi D, Kumar A et al. · Neuromolecular medicine · 2026
- 0.71
Hamdan AME, Alahdal H, Al-Zubaidy HFS et al. · Frontiers in pharmacology · 2026
- 0.71
de Souza AA, Goularte KCM, Piccoli RC et al. · Molecular neurobiology · 2025
- 0.71
JM-20 treatment prevents neuronal damage and memory impairment induced by aluminum chloride in rats
Wong-Guerra M, Montano-Peguero Y, Ramirez-Sanchez J et al. · Neurotoxicology · 2021
- 0.71
Katti VB, Kolusu AS, Madhana RM et al. · Molecular pharmaceutics · 2026
- 0.71
Timalsina B, Haque MN, Choi HJ et al. · Phytotherapy research : PTR · 2023
- 0.71
Mannan A, Mohan M, Singh S et al. · The Journal of pharmacy and pharmacology · 2025
- 0.71
Safarzadeh E, Ataei S, Akbari M et al. · Experimental gerontology · 2024
- 0.70
Exploring the Neuroprotective Effects of Rufinamide in a Streptozotocin-Induced Dementia Model
Kaur D, Grewal AK, Fouad D et al. · Cellular and molecular neurobiology · 2024
- 0.70
Bhratee A, Chatterjee D, Kaur R et al. · Metabolic brain disease · 2025
- 0.70
Ogunro OB, Karigidi ME, Gyebi GA et al. · BMC complementary medicine and therapies · 2025
- 0.70
Hooshmandi E, Rafiei E, Owjfard M et al. · Molecular biology reports · 2025
- 0.70
Baghaee P, Yoonesi M, Esfahani DE et al. · Neuroscience letters · 2024
- 0.70
Kumar P, Singh A, Kumar A et al. · Biomedicines · 2023
- 0.70
Sandeep Ganesh G, Konduri P, Kolusu AS et al. · ACS chemical neuroscience · 2023
- 0.70
Kim JH, Ra JH, Kang H et al. · Preventive nutrition and food science · 2022
- 0.70
Kopi TA, Shanehbandpour-Tabari F, Arani RM et al. · Journal of molecular neuroscience : MN · 2025
- 0.70
Bagwe Parab S, Kaur G · Brain research · 2025
- 0.70
Khalifa M, Fayed RH, Ahmed YH et al. · Psychopharmacology · 2025
- 0.70
Patel B, Sheth D, Vyas A et al. · Metabolic brain disease · 2022
- 0.70
Zuo Y, Chen B, Li X et al. · Folia morphologica · 2025
- 0.70
Comparison of Yizhiqingxin formula extraction methods and their pharmacodynamic differences
Wei W, Pei H, Ma LN et al. · Frontiers in neuroscience · 2023
- 0.69
Syed Z, Shal B, Azhar A et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
- 0.69
Zhao H, Sun Y, Hussain SA et al. · Acta pharmaceutica (Zagreb, Croatia) · 2026
- 0.69
Ebdah W, Thomas SD, Eissa N et al. · Frontiers in behavioral neuroscience · 2026
- 0.69
Sirwi A, El Sayed NS, Abdallah HM et al. · Antioxidants (Basel, Switzerland) · 2021
- 0.69
Duan L, Qian X, Wang Q et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.69
Mani V, Rashed Almutairi S · Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
- 0.69
Soylemez DO, Unur E, Sagir D · Scientific reports · 2026
- 0.69
Rezk S, Lashen S, El-Adl M et al. · Metabolic brain disease · 2022
- 0.69
Kandeda AK, Nguedia D, Ayissi ER et al. · Evidence-based complementary and alternative medicine : eCAM · 2021
- 0.69
Wrona D, Majkutewicz I, Swiatek G et al. · Journal of inflammation research · 2022
- 0.69
Altindag F, Bayir MH, Alhalboosi JKI et al. · Experimental neurology · 2026
- 0.69
Leone P, Mincheva G, Balzano T et al. · Biomedicines · 2022
- 0.69
Chen T, Shou L, Guo X et al. · Bioengineered · 2022
- 0.68
Aihaiti M, Shi H, Liu Y et al. · Food science & nutrition · 2023
- 0.68
Amraie E, Pouraboli I, Salehi H et al. · Metabolic brain disease · 2023
- 0.68
Li Q, Li X, Tian B et al. · Journal of applied toxicology : JAT · 2022
- 0.68
Allam EAH, Assi AA, Badary DM et al. · Planta medica · 2024
- 0.68
Wheatgrass extract imparts neuroprotective actions against scopolamine-induced amnesia in mice
Katiyar P, Singh Rathore A, Banerjee S et al. · Food & function · 2022
- 0.68
Elbaz EM, Ibrahim SM, Rashad E et al. · ACS chemical neuroscience · 2025
- 0.68
Neuroprotective Effect of Famotidine in Mouse Models of Alzheimer's Disease
Sadiq MH, Al-Zubaidy AA · Clinical laboratory · 2024
- 0.68
Foudah AI, Devi S, Alam A et al. · Frontiers in pharmacology · 2023
- 0.68
Khalifa M, Abdelsalam RM, Safar MM et al. · Inflammopharmacology · 2022
- 0.68
Pinky, Neha, Kaushik M et al. · Frontiers in aging neuroscience · 2026
- 0.68
Liang X, Zhang R · Disease markers · 2022
- 0.68
Ekundayo BE, Adewale OB, Obafemi BA et al. · Cell biochemistry and function · 2024
- 0.68
Isoimperatorin therapeutic effect against aluminum induced neurotoxicity in albino mice
Rajendran P, Althumairy D, Bani-Ismail M et al. · Frontiers in pharmacology · 2023
- 0.67
Wani OH, Dhaka P, Pinky et al. · Metabolic brain disease · 2026
- 0.67
Abdelmeguid NE, Khalil MIM, Elhabet R et al. · Journal of chemical neuroanatomy · 2021
- 0.67
Amenotie AJ, Ben-Azu B, Esuku DT et al. · Neurotoxicity research · 2025
- 0.67
Effects of diverse Types of Toxoplasma gondii on the outcome of Alzheimer's disease in the rat model
Galeh TM, Ghazvini H, Mohammadi M et al. · Microbial pathogenesis · 2023
- 0.67
Asgari Z, Iranzadeh S, Roghani M · Brain research bulletin · 2025
- 0.67
Faldu KG, Shah JS · Drug development research · 2024
- 0.67
Liang X, Xue Z, Zheng Y et al. · International journal of biological macromolecules · 2023
- 0.67
Ali AA, Abd El-Fattah AI, Abu-Elfotuh K et al. · International immunopharmacology · 2021
- 0.66
Liu R, Guo L, Zhao Y et al. · Brain research · 2024
- 0.66
Dash UC, Swain SK, Kanhar S et al. · Journal of ethnopharmacology · 2022
- 0.66
Portulaca oleracea L. Methanolic Extract Protects the Brain of Male Rats Against Alzheimer's Disease
El Rabey HA, Rezk SM, Mahmoud SA et al. · Scientifica · 2025
- 0.66
Hussein RA, Afifi AH, Soliman AAF et al. · Heliyon · 2020
- 0.66
Mansour HM, Fawzy HM, El-Khatib AS et al. · Neurochemistry international · 2021
- 0.66
Sun L, Dou X, Yang W · Folia morphologica · 2023
- 0.66
Bhosale S, Chakor R, Lohidasan S et al. · Journal of ethnopharmacology · 2026
- 0.66
Gupta T, Singh V, Hefnawy M et al. · ACS omega · 2023
- 0.66
Thingore C, Kshirsagar V, Juvekar A · Metabolic brain disease · 2021
- 0.66
Badawi GA, Shaaban RS, Almutairi JA et al. · Pharmaceuticals (Basel, Switzerland) · 2026
- 0.66
Digoxin Exhibits Neuroprotective Properties in a Rat Model of Dementia
Erdogan MA, Kirazlar M, Yigitturk G et al. · Neurochemical research · 2022
- 0.66
Rakshit D, Goyal R, Yadav V et al. · Nanomedicine (London, England) · 2024
- 0.66
Alzahrani NA, Bahaidrah KA, Mansouri RA et al. · Biomedicines · 2024
- 0.66
Dastan M, Rajaei Z, Sharifi M et al. · Molecular neurobiology · 2025
- 0.65
Singh Gautam A, Panda ES, Balki S et al. · Food & function · 2025
- 0.65
Xu QQ, Shaw PC, Hu Z et al. · Chinese medicine · 2021
- 0.65
Zhao H, Liu J, Wang Y et al. · Journal of the science of food and agriculture · 2023
- 0.65
Yossef RR, Al-Yamany MF, Saad MA et al. · European journal of pharmacology · 2020
- 0.65
Patel KS, Dharamsi A, Priya M et al. · Journal of ethnopharmacology · 2024
- 0.65
Sharma A, Ray A, Sathaye S et al. · Bioorganic chemistry · 2024
- 0.65
El-Maraghy SA, Reda A, Essam RM et al. · Inflammopharmacology · 2023
- 0.65
Gomaa AA, Farghaly HSM, Makboul RM et al. · BMC complementary medicine and therapies · 2022
- 0.65
Mosalam EM, Atya SM, Mesbah NM et al. · International journal of molecular sciences · 2025
- 0.65
Ameliorative effect of carveol on scopolamine-induced memory impairment in rats
Latif K, Saneela S, Khan AU · Iranian journal of basic medical sciences · 2022
- 0.65
Casagrande LdR, Medeiros EB, Venturini LM et al. · Drug delivery · 2025
- 0.65
Kandeda AK, Nguedia D, Djeuzong E et al. · Metabolic brain disease · 2022
- 0.65
Oria RS, Akpang KE, Ben RB et al. · Metabolic brain disease · 2026
- 0.65
Amooheydari Z, Rajaei Z, Alaei H et al. · Advanced biomedical research · 2022
- 0.65
Heysieattalab S, Sadeghi L · Avicenna journal of phytomedicine · 2022
- 0.65
Hassanzadeh-Taheri M, Ahmadi-Zohan A, Mohammadifard M et al. · Journal of chemical neuroanatomy · 2021
- 0.65
Hassan RM, Elsayed NS, Assaf N et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
- 0.65
Ali A, Shah SA, Zaman N et al. · Neurochemistry international · 2021
- 0.64
Zhang M, Hu Y, Zhang J et al. · Frontiers in aging neuroscience · 2020
- 0.64
Triptolide injection reduces Alzheimer's disease-like pathology in mice
Mao R, Xu S, Sun G et al. · Synapse (New York, N.Y.) · 2023
- 0.64
Sharma S, Saini A, Nehru B · Neurotoxicology · 2021
- 0.64
Orciani C, Do Carmo S, Foret MK et al. · Neurobiology of aging · 2023
- 0.64
Kashif M, Chandrabose K, Pandurangan AK · Neurochemical research · 2026
- 0.64
Akash MSH, Akbar M, Rehman K et al. · Environmental science and pollution research international · 2023
- 0.64
Liu Z, Kumar M, Kabra A · Frontiers in bioscience (Landmark edition) · 2022
- 0.64
Rajabian A, Kioumarsi Darbandi Z, Aliyari M et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2025
- 0.64
Shunan D, Yu M, Guan H et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
- 0.63
Isibor H, Ajayi AM, Ben-Azu B et al. · Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2022
- 0.63
Suman PR, Kincheski GC, Frozza RL et al. · Behavioral and brain functions : BBF · 2025
- 0.63
Askari S, Javadpour P, Rashidi FS et al. · Life (Basel, Switzerland) · 2022
- 0.63
Mahmoud AH, Ibrahim SM, El-Yamany MF et al. · Neuropharmacology · 2026
- 0.63
Neuroprotective Roles of Metformin in a Streptozotocin-Induced Dementia Model in Rats
Vizuete AFK, Moreira AP, Zin LEF et al. · Neurotoxicity research · 2025
- 0.63
Ibrahim WW, Sayed RH, Abdelhameed MF et al. · Inflammopharmacology · 2024
- 0.63
Xu J, He Z, Pan Y et al. · Biomaterials advances · 2026
- 0.63
Mansour HM, Fawzy HM, El-Khatib AS et al. · Experimental neurology · 2021
- 0.62
Faryadras K, Golchoobian R, Iranzadeh S et al. · Frontiers in neuroscience · 2025
- 0.62
Chen SY, Weng MH, Li ZY et al. · Food & function · 2022
- 0.62
Dihydroquercetin ameliorates LPS-induced neuroinflammation and memory deficit
Alam Q, Krishnamurthy S · Current research in pharmacology and drug discovery · 2022
- 0.62
Abdel-Lah ES, Sherkawy HS, Mohamed WH et al. · Inflammopharmacology · 2025
- 0.62
Khan A, Park TJ, Ikram M et al. · Molecular neurobiology · 2021
- 0.62
R N, Dubey S, Kumar D et al. · Current neurovascular research · 2026
- 0.61
Alqarni SS, Afzal M, Alharbi KS et al. · Medicina (Kaunas, Lithuania) · 2024
- 0.61
Noor NA, Hosny EN, Khadrawy YA et al. · Metabolic brain disease · 2022
- 0.61
Kumar R, Tyagi N · Recent advances in inflammation & allergy drug discovery · 2026
- 0.61
Teixeira FC, Soares MSP, Blodorn EB et al. · Molecular neurobiology · 2022
- 0.61
Neuroprotective effect of Tozasertib in Streptozotocin-induced alzheimer's mice model
Kaur D, Grewal AK, Almasoudi SH et al. · Scientific reports · 2025
- 0.60
Khodamoradi S, Khodaei F, Mohammadian T et al. · Virology journal · 2025
- 0.60
Islamie R, Myint SLL, Rojanaratha T et al. · BMC complementary medicine and therapies · 2023
- 0.60
Bhattacharjee B, Shakya A, Shivavedi N et al. · Neuroscience · 2025
- 0.60
Siraganahalli Eshwaraiah PK, Bairy KL, Kiran A et al. · European journal of pharmacology · 2026
- 0.60
Samir SM, Hassan HM, Elmowafy R et al. · Frontiers in neuroscience · 2023
- 0.59
Ibrahim MA, Haleem M, AbdelWahab SA et al. · Human & experimental toxicology · 2021
- 0.59
Xiang X, Wang X, Wu Y et al. · Pharmacology, biochemistry, and behavior · 2022
- 0.59
Khalid A, Abbasi UA, Amber S et al. · Molecular biology reports · 2020
- 0.58
Kurach L, Kulczycka-Mamona S, Kowalczyk J et al. · International journal of molecular sciences · 2021
- 0.58
Kim DS, Kang S, Moon NR et al. · International journal of molecular sciences · 2024
- 0.58
Huang J, Chen D, Lin X et al. · Hippocampus · 2023
- 0.58
El-Kazaz SES, Hafez MH, Noreldin AE et al. · Tissue & cell · 2025
- 0.58
Dastan M, Rajaei Z, Sharifi M et al. · Metabolic brain disease · 2024
- 0.58
Topal F, Ertas B, Guler E et al. · Biomaterials advances · 2022
- 0.58
Chijioke BS, Ben-Azu B, Esuku DT et al. · Biogerontology · 2026
- 0.57
Amoah V, Atawuchugi P, Jibira Y et al. · Pharmaceutical biology · 2023
- 0.57
Alfateh M, Vasconcelos C, Choker AH et al. · International journal of biological macromolecules · 2026
- 0.57
Li X, Zhang P, Li H et al. · Frontiers in behavioral neuroscience · 2022
- 0.57
Hasanabadi AJ, Beirami E, Kamaei M et al. · Experimental gerontology · 2024
- 0.57
Neuroprotective effects of dexpanthenol on streptozotocin-induced neuronal damage in rats
Erdogan MA, Yigitturk G, Erbas O et al. · Drug and chemical toxicology · 2022
- 0.57
Fikry H, Sadek DR, Saleh LA et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2026
- 0.55
Amirahmadi S, Farimani FD, Akbarian M et al. · Inflammopharmacology · 2022
- 0.55
Sayyed N, Afzal M, Rafeeq M et al. · Nutritional neuroscience · 2026
- 0.55
Visentini AE, Reichert KP, Schetinger MRC et al. · Metabolic brain disease · 2026
- 0.55
Sara Salahuddin H, Attaullah S, Ali Shah S et al. · Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
- 0.55
Nurmasitoh T, Sari DCR, Susilowati R · Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft · 2023
- 0.55
Hoveizi E, Bijavi G, Parsa H · Neurochemical research · 2025
- 0.54
Bashirrohelleh MA, Bavarsad K, Khodadadi A et al. · European journal of pharmacology · 2025
- 0.54
Arbutin attenuates monosodium L-glutamate induced neurotoxicity and cognitive dysfunction in rats
Kumar M, Kumar A, Sindhu RK et al. · Neurochemistry international · 2021
- 0.54
Afshari S, Sarailoo M, Asghariazar V et al. · Human & experimental toxicology · 2024
- 0.54
Singh L, Singh S · Neuroscience letters · 2023
- 0.53
Nadiga APR, Suman, Krishna KL · European journal of pharmacology · 2024
- 0.53
Neuropharmacological Study on Capsaicin in Scopolamine-injected Mice
Tyagi S, Thakur AK · Current Alzheimer research · 2023
- 0.53
Kodi T, Praveen S, Paka SK et al. · Advances in pharmacological and pharmaceutical sciences · 2024
- 0.52
Anwar HM, Georgy GS, Hamad SR et al. · Antioxidants (Basel, Switzerland) · 2021
- 0.52
Elseweidy MM, Mahrous M, Ali SI et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2023
- 0.51
Behera A, Pradhan SP, Tejaswani P et al. · Molecular neurobiology · 2023
- 0.51
Dey M, Singh RK · Toxicology mechanisms and methods · 2022
- 0.50
Alluri R, Kilari EK, Pasala PK et al. · Life (Basel, Switzerland) · 2023
- 0.50
In Vitro and In Vivo Neuroprotective Effects of Sarcosine
Tanas A, Tozlu OO, Gezmis T et al. · BioMed research international · 2022
- 0.50
Cardoso FDS, de Souza Oliveira Tavares C, Araujo BHS et al. · Cellular and molecular neurobiology · 2022
- 0.50
Neuroprotective Potential of Broccoli Sprout Extract in Scopolamine-Induced Memory-Impaired Mice
Jeong H, Choi H, Park YS · Foods (Basel, Switzerland) · 2025
02mice · activation318편
- 0.89
Zhu Z, Zhang L, Elsherbini A et al. · EBioMedicine · 2023
- 0.89
Liu M, Pan J, Li X et al. · Journal of neuroinflammation · 2024
- 0.88
Wang YT, Wang H, Ren WJ et al. · Journal of Asian natural products research · 2023
- 0.88
Li R, Lv ZY, Li YX et al. · Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih · 2022
- 0.88
Zhu XA, Lu H, Liu Y et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
- 0.88
Song J, Jia Y, Li J et al. · Journal of ethnopharmacology · 2022
- 0.88
Su W, Wang Y, Shao S et al. · Brain and behavior · 2024
- 0.87
Liu Y, Li M, Yu H et al. · Neurochemical research · 2026
- 0.87
Li Y, Cheng Q, Tian S et al. · Phytotherapy research : PTR · 2026
- 0.87
Yuan Q, Yang Z · Advances in clinical and experimental medicine : official organ Wroclaw Medical University · 2024
- 0.87
Ouyang X, Zhao Z, Hou Y et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- 0.87
Zhang H, Cai W, Dong L et al. · Animal models and experimental medicine · 2024
- 0.87
Wang L, Li W, Wu W et al. · Brain research · 2025
- 0.87
Guo TY, Zhang M, Lv YL et al. · The international journal of neuropsychopharmacology · 2025
- 0.87
Wang P, Sun ZY, Zhang GY et al. · Annals of medicine · 2024
- 0.87
Lian W, Wang Z, Zhou F et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2024
- 0.87
Hailati S, Yasheng Y, Yin Y et al. · Nutrients · 2026
- 0.86
Wang P, Li XL, Cao ZH · Immunobiology · 2021
- 0.86
Han C, Sheng Y, Wang J et al. · Journal of cellular physiology · 2022
- 0.86
Long QH, Wu YG, He LL et al. · Chinese medicine · 2021
- 0.86
Li H, Gao J, Chang Y et al. · International immunopharmacology · 2021
- 0.86
Sui S, Lv H · The International journal of neuroscience · 2024
- 0.86
Tang Y, Zhuo E, Li P et al. · Journal of anesthesia and translational medicine · 2025
- 0.86
Yang W, Liu Y, Xu QQ et al. · Oxidative medicine and cellular longevity · 2020
- 0.86
Berberine Ameliorates Cognitive Disorder via GSK3beta/PGC-1alpha Signaling in APP/PS1 Mice
Yang M, Wang J · Journal of nutritional science and vitaminology · 2022
- 0.86
Xie XM, Hao JJ, Shi JZ et al. · International immunopharmacology · 2023
- 0.86
Picroside II Alleviates the Progression of Alzheimer's Disease via the NLRP3/Caspase-1/GSDMD Pathway
Li S, Gao Y, Zhang Y et al. · Neuromolecular medicine · 2025
- 0.86
Zhang Y, Liu D, Yao X et al. · Neuroscience letters · 2022
- 0.86
Kang H, Zhou H, Ye Y et al. · Foods (Basel, Switzerland) · 2021
- 0.86
Hu GJ, Jiang XY, Du SY et al. · The Kaohsiung journal of medical sciences · 2024
- 0.86
Sun X, Deng Y, Ge P et al. · Journal of inflammation research · 2023
- 0.85
Feng Y, Yu X, Han J · Actas espanolas de psiquiatria · 2024
- 0.85
Li S, Wang D, Li A et al. · Molecular neurobiology · 2025
- 0.85
Liu S, Song X, Sun Y et al. · Frontiers in pharmacology · 2025
- 0.85
Olayinka J, Eduviere A, Adeoluwa O et al. · Life sciences · 2022
- 0.85
Rubiadin Alleviates Alzheimer's Disease Pathology via NF-kappaB Pathway Regulation
Zhang Y, Fan J, Nan S et al. · Journal of integrative neuroscience · 2025
- 0.85
Zhan M, Liu G, Liu YM et al. · Molecular neurobiology · 2026
- 0.85
Sotagliflozin improves cognitive deficits and attenuates neuroinflammation of Alzheimer's disease
Ning Y, Chen M, Yang H et al. · Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
- 0.85
Han L, Wei S, Wang R et al. · Biomolecules · 2025
- 0.85
Tetrahydroxy stilbene glycoside ameliorates neuroinflammation for Alzheimer's disease via cGAS-STING
Gao D, Hao JP, Li BY et al. · European journal of pharmacology · 2023
- 0.85
Kong M, Xu Z, Lu H et al. · Journal of ethnopharmacology · 2026
- 0.85
Guo Y, Cao H, Zuo C et al. · Inflammopharmacology · 2026
- 0.84
Lu J, Liu L, Chen J et al. · American journal of Alzheimer's disease and other dementias · 2022
- 0.84
Dai W, Yao RM, Mi TY et al. · Journal of psychopharmacology (Oxford, England) · 2022
- 0.84
Yuan L, Zhang J, Guo JH et al. · Journal of Alzheimer's disease : JAD · 2021
- 0.84
- 0.84
Wang Y, Ye X, Su W et al. · Metabolic brain disease · 2024
- 0.84
Wang Y, Pei H, Chen W et al. · Molecules (Basel, Switzerland) · 2023
- 0.84
Du Y, Guo T, Hao Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.84
Zhang B, Lian W, Zhao J et al. · Oxidative medicine and cellular longevity · 2021
- 0.84
Zhang X, Ma MF, Zong R et al. · The American journal of Chinese medicine · 2025
- 0.84
Ding B, Lin C, Liu Q et al. · Journal of neuroinflammation · 2020
- 0.84
Cong YF, Liu FW, Xu L et al. · The international journal of neuropsychopharmacology · 2023
- 0.84
He Y, Qiang Y · American journal of Alzheimer's disease and other dementias · 2021
- 0.84
Qin YR, Ma CQ, Wang DP et al. · American journal of translational research · 2021
- 0.84
Liu X, Song X, Zhang J et al. · Journal of ethnopharmacology · 2026
- 0.83
Xu YM, Lu FM, Xu HC et al. · Rejuvenation research · 2023
- 0.83
Xiao X, Gao F, Xie J et al. · Neurochemistry international · 2026
- 0.83
Lin LL, Song GJ, Zhang H et al. · Neuroscience · 2023
- 0.83
Du Y, Zheng X, Yue X et al. · International immunopharmacology · 2026
- 0.83
Wang Q, Liu L, Guan H et al. · Pharmaceutical biology · 2021
- 0.83
Yu X, Yu W, Wu L et al. · Neuroscience research · 2021
- 0.83
Fu XX, Duan R, Wang SY et al. · Neural regeneration research · 2023
- 0.83
USP53 promotes NOTCH2-induced neuroinflammation in Alzheimer's disease
He D, Zhao H, Zhu Y et al. · Neurochemistry international · 2026
- 0.83
Wang HP, Li MC, Yang J et al. · Degenerative neurological and neuromuscular disease · 2025
- 0.83
Zhang D, Zhang Y, Pan J et al. · CNS neuroscience & therapeutics · 2023
- 0.82
Liu Y, Han C, Guo L et al. · CNS neuroscience & therapeutics · 2025
- 0.82
Ha Y, Jo HS, Kwon TW et al. · Journal of ginseng research · 2025
- 0.82
Chen H, Chang X, Zhou J et al. · CNS & neurological disorders drug targets · 2025
- 0.82
Wang HC, Yang W, Xu L et al. · Advanced healthcare materials · 2024
- 0.82
Jiang L, Zhang Z, Luo X et al. · Life sciences · 2026
- 0.82
Liu Y, Fu R, Ge C et al. · Brain research bulletin · 2026
- 0.82
An F, Xuan X, Liu Z et al. · Molecules (Basel, Switzerland) · 2022
- 0.82
Feng X, Yu W, Guo S et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
- 0.81
- 0.81
Wongpun J, Chanmanee T, Tocharus J et al. · International immunopharmacology · 2023
- 0.81
Fu XX, Huang ZH, Wang SY et al. · Journal of inflammation research · 2024
- 0.81
Jin R, Ning X, Liu X et al. · Frontiers in cellular neuroscience · 2023
- 0.81
Xiong W, Li D, Feng Y et al. · Molecular neurobiology · 2023
- 0.81
Li X, Pan J, Liu X et al. · International immunopharmacology · 2025
- 0.81
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer's disease
Sun XY, Li LJ, Dong QX et al. · Journal of neuroinflammation · 2021
- 0.81
Jiang M, Zhang X, Yan X et al. · Brain, behavior, and immunity · 2021
- 0.81
Potential of nobiletin against Alzheimer's disease through inhibiting neuroinflammation
Chai W, Zhang J, Xiang Z et al. · Metabolic brain disease · 2022
- 0.81
Zhu XC, Liu L, Dai WZ et al. · Neural regeneration research · 2022
- 0.81
Ni H, Liao Y, Zhang Y et al. · International immunopharmacology · 2023
- 0.81
Sun X, Deng Y, Fu X et al. · Brain sciences · 2021
- 0.81
Ye F, Li M, Liu M et al. · International journal of molecular sciences · 2025
- 0.81
Wang J, Liu B, Xu Y et al. · Experimental neurology · 2022
- 0.81
Dong Y, Long S, Gu Y et al. · Neuro endocrinology letters · 2021
- 0.80
Sodium propionate improves cognitive and memory function in mouse models of Alzheimer's disease
Lang W, Li X, Wang Y et al. · Neuroscience letters · 2022
- 0.80
Ha Y, Lee R, Jeon SH et al. · The American journal of Chinese medicine · 2025
- 0.80
Liu X, Wang H, Bei J et al. · American journal of translational research · 2021
- 0.80
Abuelezz SA, Hendawy N · Life sciences · 2021
- 0.80
Xie L, Liu Y, Zhang N et al. · Frontiers in neuroscience · 2021
- 0.80
Hu W, Li Z, Wang W et al. · Food & function · 2021
- 0.80
Photobiomodulation of immune crosstalk rescues neuroinflammation in Alzheimer's disease models
Shen Q, Chang H, Li J et al. · Brain : a journal of neurology · 2026
- 0.80
Wang G, Hiramoto K, Ma N et al. · International journal of molecular sciences · 2026
- 0.80
Kou JJ, Shi JZ, He YY et al. · Acta pharmacologica Sinica · 2022
- 0.80
Wang Y, Lin Y, Wang L et al. · Aging · 2020
- 0.80
Yin H, Liu R, Bie L · Aging · 2024
- 0.80
Hu Y, Cui J, Sun J et al. · Journal of nanobiotechnology · 2024
- 0.80
Zhou J, Zhang W, Yang Y et al. · Chinese journal of natural medicines · 2026
- 0.80
Li T, Chen J, Xie Z et al. · Frontiers in pharmacology · 2025
- 0.79
Ren D, Fu Y, Wang L et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021
- 0.79
Abeta promotes CD38 expression in senescent microglia in Alzheimer's disease
Hu Y, Huang Y, Xing S et al. · Biological research · 2022
- 0.79
Lei S, Wu S, Wang G et al. · Neuroreport · 2021
- 0.79
Kim T, Cho J, Kang H · Scientific reports · 2025
- 0.79
Yan T, Zhang X, Mao Q et al. · Environmental toxicology · 2022
- 0.79
Cornuside Is a Potential Agent against Alzheimer's Disease via Orchestration of Reactive Astrocytes
Shi JZ, Zheng XM, Zhou YF et al. · Nutrients · 2022
- 0.79
Ye X, Shao S, Wang Y et al. · Journal of chemical neuroanatomy · 2023
- 0.79
TLR4/Rac1/NLRP3 Pathway Mediates Amyloid-beta-Induced Neuroinflammation in Alzheimer's Disease
Zhu M, Liu Y, Chen C et al. · Journal of Alzheimer's disease : JAD · 2024
- 0.79
Orti-Casan N, Zuhorn IS, Naude PJW et al. · Proceedings of the National Academy of Sciences of the United States of America · 2022
- 0.79
Qiu Y, Zhao Y, He G et al. · Immunity, inflammation and disease · 2025
- 0.79
Zunyimycin C enhances immunity and improves cognitive impairment and its mechanism
Wang X, Li Z, Sun R et al. · Frontiers in cellular and infection microbiology · 2022
- 0.79
You M, Wang K, Pan Y et al. · Food & function · 2022
- 0.78
Shi K, Chen L, Chen L et al. · Journal of ethnopharmacology · 2022
- 0.78
Gui S, Zeng F, Wu Z et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.78
Chen B, Wu J, Hu S et al. · Neurochemical research · 2023
- 0.78
Hesperetin attenuates cognitive dysfunction via SIRT6/NLRP3 pathway in scopolamine-induced mice
Jing S, Wang X, Zhang Z et al. · Metabolic brain disease · 2023
- 0.78
SARM1 Promotes Neurodegeneration and Memory Impairment in Mouse Models of Alzheimer's Disease
Miao X, Wu Q, Du S et al. · Aging and disease · 2024
- 0.78
The anesthetic sevoflurane induces tau trafficking from neurons to microglia
Dong Y, Liang F, Huang L et al. · Communications biology · 2021
- 0.78
Chen Q, Yin Y, Li L et al. · Neuropsychiatric disease and treatment · 2021
- 0.78
Hu H, Cheng Q, Li D et al. · International immunopharmacology · 2026
- 0.78
Jiao H, Huang H, Chen S et al. · Pathology, research and practice · 2026
- 0.78
Cui D, Liu S, Liu Y et al. · Journal of neuroinflammation · 2026
- 0.77
Butyrate antagonizes Annexin A2-mediated tauopathy via Annexin A1 reciprocity in Alzheimer's disease
Jayaswamy PK, Ambrish T, Sangamesh VC et al. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2026
- 0.77
- 0.77
Balakrishnan R, Kim YS, Kim GW et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
- 0.77
Orti-Casan N, Wajant H, Kuiperij HB et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.77
Lupeol protect against LPS-induced neuroinflammation and amyloid beta in adult mouse hippocampus
Choe K, Park JS, Park HY et al. · Frontiers in nutrition · 2024
- 0.77
Hu K, Gao W, Pan J et al. · Journal of ethnopharmacology · 2027
- 0.77
Sun Z, Liu J, Chen Z et al. · CNS neuroscience & therapeutics · 2024
- 0.77
Chen F, Yang D, Cheng XY et al. · Biological & pharmaceutical bulletin · 2021
- 0.77
Hou J, Wang X, Zhang J et al. · Drug design, development and therapy · 2024
- 0.77
3,6'-Disinapoyl sucrose alleviates cognitive deficits in APP/PS1 transgenic mice
Yuan J, He M, Dai X et al. · Journal of neurophysiology · 2023
- 0.77
Jang BK, Shin SJ, Park HH et al. · Pharmaceutics · 2024
- 0.77
Atiq A, Choe K, Kang MH et al. · Molecular neurobiology · 2026
- 0.77
Zhu L, Zhou T, Wu L et al. · Scientific reports · 2025
- 0.77
Qin YR, Ma CQ, Jiang JH et al. · Journal of neurochemistry · 2022
- 0.77
Tooth Loss Induces Memory Impairment and Gliosis in App Knock-In Mouse Models of Alzheimer's Disease
Taslima F, Jung CG, Zhou C et al. · Journal of Alzheimer's disease : JAD · 2021
- 0.77
Zheng R, Liu X, Liao Z et al. · Experimental neurology · 2026
- 0.77
Wang J, Du L, Zhang T et al. · Neuropharmacology · 2024
- 0.77
Trilobatin Alleviates Cognitive Deficits and Pathologies in an Alzheimer's Disease Mouse Model
Ding J, Huang J, Yin D et al. · Oxidative medicine and cellular longevity · 2021
- 0.77
Ali MM, Sayed RH, Wadie W et al. · European journal of pharmacology · 2025
- 0.77
Kim SH, Ko YJ, Kim JY et al. · International neurourology journal · 2021
- 0.77
Sohn E, Kim YJ, Kim JH et al. · Frontiers in pharmacology · 2021
- 0.77
2'-Fucosyllactose Ameliorates Cognitive Impairment and Neuroinflammation in AD Mice
Ma Y, Zhang M, Jin Y et al. · Journal of agricultural and food chemistry · 2025
- 0.76
Weng Y, He T, Li M et al. · Frontiers in immunology · 2026
- 0.76
Wu H, Xia J, Shi Z et al. · Neurochemical research · 2026
- 0.76
Ren H, Tang L, Yuan Z et al. · Frontiers in pharmacology · 2024
- 0.76
Wu J, Chen J, Ge Y et al. · Heliyon · 2024
- 0.76
Porphyromonas gingivalis-Induced NETs Mediate Neuroinflammation via TLR4 Activation
Xu L, Zhou Y, Chen H et al. · Journal of dental research · 2026
- 0.76
Chen QY, Yin Y, Li L et al. · The journal of prevention of Alzheimer's disease · 2022
- 0.76
Li QM, Zhang-Yang QQ, Tan YY et al. · International journal of biological macromolecules · 2026
- 0.76
Zhang B, Wang J, Chen J et al. · Ecotoxicology and environmental safety · 2025
- 0.76
Early intervention attenuates synaptic plasticity impairment and neuroinflammation in 5xFAD mice
Li K, Wang X, Jiang Y et al. · Journal of psychiatric research · 2021
- 0.75
Mu L, Xia D, Cai J et al. · International journal of molecular sciences · 2022
- 0.75
- 0.75
Dai YT, Chen Q, Ma YD et al. · Neuropharmacology · 2026
- 0.75
Zhuang C, Yan H, Lu J et al. · Frontiers in physiology · 2025
- 0.75
Bu J, Zhang Y, Mahan Y et al. · Translational neuroscience · 2022
- 0.75
Ruganzu JB, Zheng Q, Wu X et al. · Experimental neurology · 2021
- 0.75
Zhang Y, Chen JC, Zheng JH et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024
- 0.75
Wang W, Xing Y, Xu Z et al. · Frontiers in pharmacology · 2026
- 0.75
Zhong M, Xu QQ, Hu Z et al. · Journal of ethnopharmacology · 2024
- 0.75
- 0.75
Zhang DQ, Li G, Fu ZD et al. · Neuropharmacology · 2025
- 0.75
Targeting lncRNA NEAT1 Hampers Alzheimer's Disease Progression
Li Y, Fan H, Ni M et al. · Neuroscience · 2023
- 0.75
Catalpol rescues cognitive deficits by attenuating amyloid beta plaques and neuroinflammation
Li S, Tian Z, Xian X et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
- 0.75
CD22 modulation alleviates amyloid beta-induced neuroinflammation
Mai YD, Zhang Q, Fung CL et al. · Journal of neuroinflammation · 2025
- 0.75
Wang SM, Chuu JJ, Lee CK et al. · Heliyon · 2023
- 0.74
Wang X, Li Z, Li C et al. · Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan · 2020
- 0.74
Choe K, Ahmad R, Kang MH et al. · Cell communication and signaling : CCS · 2025
- 0.74
Chen R, Zhang Q, Yan Y et al. · Molecular neurobiology · 2021
- 0.74
Fan L, Zhaohong X, Xiangxue W et al. · BioMed research international · 2022
- 0.74
Kim YS, Lee SB, Kang SI et al. · International journal of molecular sciences · 2025
- 0.74
Li S, Zhang X, Zhang P et al. · Molecular nutrition & food research · 2026
- 0.74
An FM, Liu Z, Xuan XR et al. · Journal of ethnopharmacology · 2021
- 0.74
Li W, Huang W, Zhou P et al. · Frontiers in pharmacology · 2025
- 0.74
Divya, Faruq M, Nazir SS et al. · Journal of neurochemistry · 2025
- 0.74
Jiang Y, Chen H, Xu J et al. · Food & function · 2025
- 0.74
He L, Sun J, Miao Z et al. · Heliyon · 2023
- 0.74
Trofinetide Improves Cognitive Function in APP/PS1 Mice by Suppressing Inflammation and Apoptosis
Chen M, Ning Y, Yang H et al. · Molecular neurobiology · 2025
- 0.74
Kim MW, Choe K, Park JS et al. · Cells · 2022
- 0.74
Tang L, Xiang Q, Xiang J et al. · Bioengineered · 2021
- 0.74
Shan X, Lv S, Huang P et al. · Molecular neurobiology · 2024
- 0.73
Liu LZ, Fan SJ, Gao JX et al. · Brain research bulletin · 2023
- 0.73
Liu J, Jiang J, He C et al. · Frontiers in aging neuroscience · 2024
- 0.73
Suo X, Wan P, Yu J et al. · Neurochemical research · 2026
- 0.73
Liu S, Fan M, Xu JX et al. · Journal of neuroinflammation · 2022
- 0.73
Wang D, Zhao Z, Ding Y · Acta pharmaceutica (Zagreb, Croatia) · 2026
- 0.73
Tang JJ, Huang LF, Deng JL et al. · Redox biology · 2022
- 0.73
Xu Z, Liu C, Wang R et al. · The Journal of nutritional biochemistry · 2021
- 0.73
NaoXinTong Capsule ameliorates memory deficit in APP/PS1 mice by regulating inflammatory cytokines
Wang X, Yin Z, Cao P et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
- 0.73
The Neuroprotective Effect of Byu d Mar 25 in LPS-Induced Alzheimer's Disease Mice Model
Liu L, Zhang Y, Tang L et al. · Evidence-based complementary and alternative medicine : eCAM · 2021
- 0.73
Gardenia jasminoides J.Ellis extract GJ-4 alleviated cognitive deficits of APP/PS1 transgenic mice
Zang C, Liu H, Shang J et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021
- 0.73
Wang C, Bu X, Cao M et al. · BMC neuroscience · 2025
- 0.73
Lu L, Fu Z, Wu B et al. · Translational neuroscience · 2023
- 0.73
A Novel Missense Variant in SORBS2 Is Causative With Familial Alzheimer's Disease
Wang Q, Wang S, Cao S et al. · CNS neuroscience & therapeutics · 2025
- 0.73
Sun X, Liu H, Li W et al. · Journal of inflammation (London, England) · 2025
- 0.73
Ruganzu JB, Peng X, He Y et al. · Molecular immunology · 2022
- 0.73
Li B, Wang L, Xiao Y et al. · Phytotherapy research : PTR · 2025
- 0.73
Zhang J, Zhang J · Nutrients · 2025
- 0.73
Shao S, Ye X, Su W et al. · Journal of chemical neuroanatomy · 2023
- 0.72
Wu S, Liu W, Zhang C · Neurological research · 2026
- 0.72
Fan M, Liu S, Sun HM et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
- 0.72
Ullah R, Ali G, Baseer A et al. · International immunopharmacology · 2022
- 0.72
Li Q, Peng J, Luo Y et al. · Journal of neuroinflammation · 2022
- 0.72
Ameliorating Alzheimer's-like Pathology by Minocycline via Inhibiting Cdk5/p25 Signaling
Zhao Y, Wang C, He W et al. · Current neuropharmacology · 2022
- 0.72
Ou H, Chen R, Zhou L et al. · International immunopharmacology · 2026
- 0.72
Li X, Huang L, Kong L et al. · Molecular medicine reports · 2023
- 0.72
Li X, Wu Z, Yao C et al. · Research (Washington, D.C.) · 2026
- 0.72
Li WY, Lee CY, Lee KM et al. · Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
- 0.72
Quan W, Luo Q, Hao W et al. · Glia · 2021
- 0.72
Yu C, Li M, Shen F et al. · Chinese medicine · 2025
- 0.71
Kuang Y, Zhu M, Gu H et al. · Journal of ethnopharmacology · 2024
- 0.71
Ge P, Guo S, Wang P et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
- 0.71
Kaur S, Sharma K, Sharma A et al. · Frontiers in immunology · 2024
- 0.71
Wang C, Xu X, Zhu H et al. · Journal of ethnopharmacology · 2026
- 0.71
Gao J, Wang L, Zhao C et al. · Journal of leukocyte biology · 2021
- 0.71
Shao L, Dong C, Geng D et al. · Metabolic brain disease · 2022
- 0.71
Ban S, Do TT, Pyo JW et al. · International journal of molecular sciences · 2025
- 0.71
Pei H, He Z, Du R et al. · Molecular neurobiology · 2025
- 0.71
Erinacine C Attenuates Alzheimer's-like Pathology: A Study in APP/PS1 Mice and PC12 Cells
Wang LY, Yeh SL, Hsu ST et al. · Molecules (Basel, Switzerland) · 2026
- 0.71
Wang SY, Huang ZH, Duan R et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.71
Ding T, Song M, Wu Y et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
- 0.71
Qiu H, Liu X · Molecular neurobiology · 2022
- 0.71
Guo D, Xu Y, Wang Y et al. · Behavioural brain research · 2023
- 0.71
Park J, Kim Y, Lee JE et al. · Journal of microbiology and biotechnology · 2025
- 0.70
Ali W, Choe K, Park JS et al. · Frontiers in pharmacology · 2024
- 0.70
Yang C, Zhao E, Zhang H et al. · Frontiers in pharmacology · 2024
- 0.70
Xia X, He X, Zhao T et al. · Cell proliferation · 2024
- 0.70
Li JQ, Ma XH, Dai H et al. · Journal of ethnopharmacology · 2025
- 0.70
Chen C, Lan Z, Tang X et al. · Annals of neurology · 2024
- 0.69
Liang Y, Kang X, Zhang H et al. · Journal of neuroinflammation · 2023
- 0.69
Gaber A, Elbakry AM, Aljarari RM et al. · Stem cells international · 2023
- 0.69
Li Y, Zhang J, Zhang L et al. · European journal of pharmacology · 2025
- 0.69
Yun Q, Ma SF, Zhang WN et al. · Cellular and molecular neurobiology · 2024
- 0.69
Huang Y, Wei F, Cheng X et al. · Bioscience trends · 2025
- 0.69
Yang G, Hu Y, Qin X et al. · Heliyon · 2023
- 0.69
Liu C, Wang X, Xu W et al. · Pharmaceuticals (Basel, Switzerland) · 2025
- 0.69
Chu H, Sun Y, Huang C et al. · International journal of nanomedicine · 2026
- 0.68
Takada N, Nakamura Y, Ikeda K et al. · Neurochemical research · 2021
- 0.68
Guan P, Zhu D, Wang P · Molecular neurobiology · 2023
- 0.68
Liu Y, Meng XK, Shao WZ et al. · Neurochemical research · 2024
- 0.68
Silk fibroin@polydopamine for acupoint catgut-embedding therapy in Alzheimer's disease
Wang C, Liu X, Fan Y et al. · Journal of integrative medicine · 2026
- 0.68
TMEM16F may be a new therapeutic target for Alzheimer's disease
Cui ZQ, Hu XY, Yang T et al. · Neural regeneration research · 2023
- 0.67
Zou J, Liu L, Chai F et al. · Molecular neurobiology · 2025
- 0.67
Liang C, Zou T, Zhang M et al. · Theranostics · 2021
- 0.67
Oh KN, Bae D, Oh DR et al. · Journal of microbiology and biotechnology · 2025
- 0.67
Zhang H, Bi F, Zhao P et al. · Journal of ethnopharmacology · 2025
- 0.67
Ruan S, Zhai L, Wu S et al. · Aging · 2021
- 0.67
Yang W, Yu Q, Wang N et al. · Neuromolecular medicine · 2025
- 0.67
Puntambekar SS, Moutinho M, Lin PBC et al. · Molecular neurodegeneration · 2022
- 0.67
Nam Y, Ji YJ, Shin SJ et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
- 0.67
Zhang ZH, Pei YH, Duan ZH et al. · International journal of biological macromolecules · 2025
- 0.66
Zhang H, Zhang C, Wang Q et al. · Environmental pollution (Barking, Essex : 1987) · 2024
- 0.66
Xu Y, Shao N, Zhi F et al. · Alzheimer's research & therapy · 2025
- 0.66
ADAM17 Inhibition Protects Cognition in Intermittent Hypoxia: The Role of TREM2
Xu J, Jin H, Li X et al. · Nature and science of sleep · 2025
- 0.66
Zhao X, Ge P, Lei S et al. · Drug design, development and therapy · 2023
- 0.65
Qu C, Qu C, Xu L et al. · Brain research bulletin · 2021
- 0.65
Targeting IGF2BP2 alleviates high fat diet aggravated Alzheimer's disease by inhibiting ferroptosis
Zhang D, Shao L, He M et al. · Brain research bulletin · 2026
- 0.65
Chen P, Chen F, Lei J et al. · Phytotherapy research : PTR · 2023
- 0.64
Cai H, Qiao J, Chen S et al. · Acta biochimica et biophysica Sinica · 2022
- 0.64
Naringenin ameliorates amyloid-beta pathology and neuroinflammation in Alzheimer's disease
Zhu Y, Guo X, Li S et al. · Communications biology · 2024
- 0.64
Hu K, Wu S, Xu J et al. · Journal of agricultural and food chemistry · 2024
- 0.64
Chiu YJ, Lin CH, Lee MC et al. · Aging · 2021
- 0.64
Wang L, Sun J, Miao Z et al. · Neuroreport · 2022
- 0.63
Wang G, Wang X, Zheng X et al. · Neuroscience research · 2022
- 0.63
Isovitexin modulates autophagy in Alzheimer's disease via miR-107 signalling
Cheng J, Wang G, Zhang N et al. · Translational neuroscience · 2020
- 0.63
Shang C, Su Y, Ma J et al. · Frontiers in pharmacology · 2024
- 0.63
Liu D, Yang H, Feng X et al. · Experimental gerontology · 2026
- 0.63
Zhu H, Zhang T, Li R et al. · Metabolic brain disease · 2024
- 0.62
Cai M, Zhang X, Gao X et al. · International journal of biological macromolecules · 2025
- 0.62
Xie Z, Meng J, Kong W et al. · Aging cell · 2022
- 0.62
Gui S, Ni J, Mizutani S et al. · Food science & nutrition · 2024
- 0.62
Interleukin-10 deficiency exacerbates inflammation-induced tau pathology
Weston LL, Jiang S, Chisholm D et al. · Journal of neuroinflammation · 2021
- 0.62
IL-17A promotes the progression of Alzheimer's disease in APP/PS1 mice
Cao M, Liu J, Zhang X et al. · Immunity & ageing : I & A · 2023
- 0.62
Bang SI, Seo WT, Lee S et al. · Food science and biotechnology · 2025
- 0.61
Meng Q, Li J, Xu G et al. · Journal of biochemical and molecular toxicology · 2026
- 0.61
Wang X, Xiang X, Hu J et al. · Journal of molecular neuroscience : MN · 2022
- 0.60
Karimi-Zandi L, Zahmatkesh M, Hassanzadeh G et al. · Cytokine · 2022
- 0.59
Wang J, Liu B, Sun F et al. · International immunopharmacology · 2022
- 0.59
Cheng Q, Ma X, Liu J et al. · International journal of molecular sciences · 2023
- 0.59
Noninvasive Terahertz Wave Binocular Stimulation Improves Cognition in Amyloid-beta-Related Dementia
Wu H, Zhang T, Ma J et al. · Research (Washington, D.C.) · 2026
- 0.59
Yang X, Zhi J, Leng H et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021
- 0.59
Yin C, Zhang M, Cheng L et al. · Frontiers in pharmacology · 2024
- 0.59
Nakano M, Kubota K, Hashizume S et al. · Brain, behavior, & immunity - health · 2020
- 0.58
Akhbari M, Babaei F, Navidi-Moghaddam A et al. · IBRO neuroscience reports · 2026
- 0.58
Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
Cai Y, Chai Y, Fu Y et al. · Frontiers in aging neuroscience · 2021
- 0.58
Chen WX, Huang QY, Sun JH et al. · Journal of Asian natural products research · 2026
- 0.58
Ullah S, Park TJ, Park JS et al. · Frontiers in immunology · 2025
- 0.58
Inhibition of miR-25-3p Alleviates Neuroinflammation in Alzheimer's Disease By Targeting ADAM10
Chen P, Qiang X, Zhao Z et al. · Molecular neurobiology · 2026
- 0.58
Kumari E, Xu A, Chen R et al. · Experimental neurology · 2023
- 0.57
Liu D, Li X, Shi P et al. · Psychopharmacology · 2026
- 0.57
Sasaki K, Geribaldi-Doldan N, Szele FG et al. · Aging · 2021
- 0.57
Chu X, Qi Z, Li S et al. · European journal of pharmacology · 2026
- 0.57
Lim JY, Lee JE, Lee M et al. · Translational neurodegeneration · 2026
- 0.57
Chen F, Wu X, Yang J et al. · European journal of pharmacology · 2022
- 0.57
- 0.56
Sha S, Shen X, Cao Y et al. · Aging · 2021
- 0.56
Salama A, Elgohary R, Elesawy WH · Molecular neurobiology · 2026
- 0.56
Chen P, Guo Z, Lei J et al. · Phytotherapy research : PTR · 2024
- 0.55
Yang R, Deng MY, Yang LK et al. · Free radical biology & medicine · 2025
- 0.55
Jie F, Yang X, Yang B et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
- 0.54
Xiao Y, Dai Y, Li L et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2021
- 0.54
Tanzi R, Castro R, Gavrilles E et al. · Research square · 2026
- 0.53
Xiang X, Wang X, Jin S et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2022
- 0.53
Wei PC, Lee-Chen GJ, Chen CM et al. · Oxidative medicine and cellular longevity · 2022
- 0.52
Aquino R, de Concini V, Dhenain M et al. · Cells · 2023
- 0.52
Zou H, Chen X, Lu J et al. · Neurochemistry international · 2023
- 0.51
Eo H, Lee S, Kim SH et al. · Food & function · 2022
- 0.51
Xie R, Lin X, Chen S et al. · Atherosclerosis · 2026
- 0.51
Wang Q, Sun L, Ma J et al. · Journal of neuroinflammation · 2025
- 0.51
Fan M, Wang C, Zhao X et al. · International immunopharmacology · 2023
- 0.51
Lee S, Ryu SM, Kim DH et al. · Journal of ethnopharmacology · 2022
- 0.51
Wang Z, Li T, Du M et al. · Brain research bulletin · 2023
- 0.50
Huang X, Xu G, Zhou Y et al. · Materials today. Bio · 2026
03mice · gut microbiota266편
- 0.91
Lyra E Silva NM, Goncalves RA, Pascoal TA et al. · Translational psychiatry · 2021
- 0.90
Xiong W, Zhao X, Xu Q et al. · Journal of ethnopharmacology · 2022
- 0.89
Qu C, Li QP, Su ZR et al. · Journal of advanced research · 2022
- 0.88
Qiao O, Zhang X, Zhang Y et al. · Chinese medicine · 2021
- 0.88
Wu Y, Shao Y, Shao X et al. · International journal of biological macromolecules · 2025
- 0.87
Kim Y, Cho M, Woo Y et al. · Food science and biotechnology · 2026
- 0.87
Jia M, Ning F, Wen J et al. · Journal of neuroinflammation · 2024
- 0.86
Cai Y, Han S, Zhao M et al. · Journal of oral microbiology · 2026
- 0.86
Sugandhi VV, Gattu K, Mundrathi V et al. · International journal of pharmaceutics · 2025
- 0.86
Eissa N, Alwattar JK, Jayaprakash P et al. · International journal of nanomedicine · 2026
- 0.86
Shiqing Y, Xinjie L, Xiaotong Z et al. · Microbiology spectrum · 2025
- 0.85
You J, Liu Q, Li X · Frontiers in immunology · 2026
- 0.85
Ling Z, Xu X, Cheng Y et al. · Free radical biology & medicine · 2026
- 0.85
Wang XY, Wang YY, Zhang J et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
- 0.84
Ling Z, Cheng Y, Xu X et al. · Frontiers in immunology · 2026
- 0.84
Sola-Sevilla N, Mesa-Lombardo A, Aleixo M et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2023
- 0.84
Zahedi E, Sanaeierad A, Nikbakhtzadeh M et al. · Behavioural brain research · 2023
- 0.84
Mo C, Bajgai J, Rahman MH et al. · Antioxidants (Basel, Switzerland) · 2026
- 0.83
Yue X, Zhou Y, Qiao M et al. · Alzheimer's research & therapy · 2021
- 0.83
Jiang J, Liu H, Wang Z et al. · PloS one · 2021
- 0.83
Lykhmus O, Tzeng WY, Koval L et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
- 0.83
Fang S, Xi H, Zhang K et al. · Frontiers in microbiology · 2026
- 0.83
Liu J, Liu K, Cui X et al. · Biochemical and biophysical research communications · 2025
- 0.83
Ma X, Kim JK, Shin YJ et al. · Nutrients · 2023
- 0.83
Zahedi E, Naseri FM, Zamani E et al. · Molecular neurobiology · 2025
- 0.83
Xie Z, Lu H, Yang S et al. · Frontiers in pharmacology · 2020
- 0.83
He C, Jiang J, Liu J et al. · International journal of biological macromolecules · 2024
- 0.83
Ameliorative effects of probiotics in AlCl(3)-induced mouse model of Alzheimer's disease
Hamid M, Zahid S · Applied microbiology and biotechnology · 2023
- 0.83
A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers
Marizzoni M, Mirabelli P, Mombelli E et al. · Alzheimer's research & therapy · 2023
- 0.83
Almazan JL, Cortes-Flores E, Ramirez-Olvera A et al. · Brain, behavior, and immunity · 2025
- 0.83
Pan S, Zhang Y, Ye T et al. · Molecular nutrition & food research · 2024
- 0.83
Tian M, Wang D, Zhang C et al. · ACS chemical neuroscience · 2026
- 0.82
Losartan Improves Memory, Neurogenesis and Cell Motility in Transgenic Alzheimer's Mice
Drews HJ, Klein R, Lourhmati A et al. · Pharmaceuticals (Basel, Switzerland) · 2021
- 0.82
Wu Y, Niu X, Li P et al. · Archives of microbiology · 2023
- 0.82
Jin D, Zhang M, Shi L et al. · The international journal of neuropsychopharmacology · 2024
- 0.82
Song Z, He J, Yu W et al. · Frontiers in microbiology · 2024
- 0.82
Wang Y, Xu B, Zhou J et al. · Acta neurobiologiae experimentalis · 2021
- 0.82
He J, Jin Y, He C et al. · Frontiers in pharmacology · 2023
- 0.81
Zhu Y, Li L, Jin X et al. · International journal of biological macromolecules · 2024
- 0.81
Sun J, Zhang Y, Kong Y et al. · Brain, behavior, and immunity · 2022
- 0.81
Chen Y, Chen X, Luo Z et al. · Journal of advanced research · 2025
- 0.81
Arandelovic J, Santrac A, Batinic B et al. · CNS neuroscience & therapeutics · 2022
- 0.81
Li Z, Wang H, Yuan H et al. · Pharmaceuticals (Basel, Switzerland) · 2026
- 0.81
Zhou S, Yue C, Wang P et al. · Experimental neurology · 2026
- 0.81
Liu C, Zhang T, E ED et al. · Translational psychiatry · 2026
- 0.80
Wang J, Liao M, Tong Z et al. · Molecular neurobiology · 2025
- 0.80
Lapmanee S, Thonapan N, Sriwong S et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
- 0.80
Hochuli N, Kadyan S, Park G et al. · Molecular neurobiology · 2025
- 0.80
Effect of C-phycocyanin on HDAC3 and miRNA-335 in Alzheimer's disease
Li Z, Gan L, Yan S et al. · Translational neuroscience · 2020
- 0.80
Ma X, Kim JK, Shin YJ et al. · Brain, behavior, and immunity · 2024
- 0.80
Song M, Zhang S, Gan Y et al. · Journal of agricultural and food chemistry · 2025
- 0.80
Tang Z, Wang XL, Deng YX et al. · Cell biochemistry and biophysics · 2025
- 0.80
Trojan E, Curzytek K, Cieslik P et al. · Neurobiology of disease · 2023
- 0.80
Lee S, Yoo YJ, Kim G et al. · International journal of molecular sciences · 2026
- 0.80
Zhou C, Feng X, Liu H et al. · Frontiers in neuroscience · 2025
- 0.79
Gao P, Wang Z, Lei M et al. · Pharmacological research · 2022
- 0.79
Li Y, Ye T, Lu H et al. · Journal of visualized experiments : JoVE · 2026
- 0.79
Oxytocin Nanogels Inhibit Innate Inflammatory Response for Early Intervention in Alzheimer's Disease
Ye C, Cheng M, Ma L et al. · ACS applied materials & interfaces · 2022
- 0.79
Pu D, Jin Y, Wang L et al. · Neurochemistry international · 2025
- 0.79
Lee DY, Shin YJ, Kim JK et al. · Food & function · 2021
- 0.79
Song Y, Pan W, Meng L et al. · Foods (Basel, Switzerland) · 2025
- 0.79
Zhang H, Kou J, Ge P et al. · Frontiers in microbiology · 2026
- 0.79
Bhuiyan P, Zhang W, Liang G et al. · bioRxiv : the preprint server for biology · 2024
- 0.79
Wang B, Pan M, Yang L et al. · Alzheimer's research & therapy · 2026
- 0.79
Bartholomew SK, Winslow W, Sharma R et al. · Journal of neuroinflammation · 2024
- 0.79
de Munter J, Chaprov K, Lang E et al. · Cells · 2025
- 0.79
Li N, Wang S, Li H et al. · Journal of agricultural and food chemistry · 2025
- 0.79
Kokhan VS, Nesterov MS, Levashova AI · Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections · 2023
- 0.78
Chen L, Xiong L, Yao L et al. · Alzheimer's research & therapy · 2023
- 0.78
Pan X, Su Z, Huang Z et al. · Translational psychiatry · 2025
- 0.78
Luo S, Tamada A, Saikawa Y et al. · Aging and disease · 2024
- 0.78
Gao PP, Zhou FL, Zheng GB et al. · Frontiers in nutrition · 2026
- 0.78
Kim N, Jeon SH, Ju IG et al. · Brain, behavior, and immunity · 2021
- 0.78
Zhang S, Lv S, Li Y et al. · European journal of nutrition · 2023
- 0.78
Luo QH, Li F, Yang L et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
- 0.78
Francesca F, Caitlin A, Sarah L et al. · Brain, behavior, & immunity - health · 2022
- 0.78
Hughes TR, Webberley TS, John D et al. · Frontiers in neuroscience · 2026
- 0.77
Cheng J, Li W, Wang L et al. · Journal of inflammation research · 2024
- 0.77
Caffeic acid protects against atherosclerotic lesions and cognitive decline in ApoE(-/-) mice
Sun R, Wu T, Xing S et al. · Journal of pharmacological sciences · 2023
- 0.77
Cheng X, Chi L, Lin T et al. · Journal of neuroinflammation · 2023
- 0.77
Zeng L, Zhang D, Liu Q et al. · Neuroscience · 2021
- 0.77
Hosseinkhani F, Chevalier C, Marizzoni M et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.77
Kim Y, Cho M, Jang CH et al. · Foods (Basel, Switzerland) · 2024
- 0.77
Zhang X, Xie T, Zhou S et al. · Food & function · 2024
- 0.77
Chia seeds as a potential cognitive booster in the APP23 Alzheimer's disease model
Schreyer S, Klein C, Pfeffer A et al. · Scientific reports · 2020
- 0.77
Yang X, Ye T, He Y et al. · Frontiers in neurology · 2023
- 0.77
Nakagawa K, Kodama K, Nagata W et al. · Behavioural brain research · 2025
- 0.77
Sex-Dependent Effects of Intestinal Microbiome Manipulation in a Mouse Model of Alzheimer's Disease
Kaur H, Nookala S, Singh S et al. · Cells · 2021
- 0.77
Elfiky AM, Shahy EM, Mahmoud AA · Physiology & behavior · 2026
- 0.77
Intranasal triptolide in mice: a strategy to reduce neuroinflammation and boost cognitive function
Yan M, Zhang L, Zhao J et al. · Immunopharmacology and immunotoxicology · 2026
- 0.77
Li Z, Tan B, Dong K et al. · Biochemical pharmacology · 2026
- 0.77
Niazi NUK, Yang Z, Zhang Y et al. · Prostaglandins, leukotrienes, and essential fatty acids · 2025
- 0.76
Mosaferi B, Jand Y, Salari AA · Brain research bulletin · 2021
- 0.76
Gao Y, Zhang CS, Liang Y et al. · The American journal of Chinese medicine · 2025
- 0.76
Flores J, Fillion ML, LeBlanc AC · Cell death & disease · 2022
- 0.76
Chen J, Zou C, Guan H et al. · CNS neuroscience & therapeutics · 2024
- 0.76
Kang S, Lee J, Choi S et al. · Research square · 2023
- 0.76
Tettevi EJ, Simpong DL, Maina M et al. · Brain and behavior · 2025
- 0.76
Wang X, Ge X, Di X et al. · Food science & nutrition · 2026
- 0.76
Maruthiyodan S, Munegowda G, Thomas M et al. · Journal of ethnopharmacology · 2026
- 0.75
Zhang P, Liu Y, Jin X et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.75
Sanders B, Korthauer M, Parihar KS et al. · bioRxiv : the preprint server for biology · 2026
- 0.75
Flores J, Noel A, Fillion ML et al. · Cell death and differentiation · 2022
- 0.75
Li J, Cheng S, Zhang W et al. · Biology · 2026
- 0.75
Matsuzaki Tada A, Hamezah HS, Pahrudin Arrozi A et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.75
Kim JH, Lim DK, Suh YH et al. · Antioxidants (Basel, Switzerland) · 2021
- 0.75
Chaulagain B, Gothwal A, Mahanta AK et al. · ACS chemical neuroscience · 2026
- 0.75
Maskery M, Goulding EM, Gengler S et al. · American journal of Alzheimer's disease and other dementias · 2020
- 0.75
Liu J, Ren G, Niu S et al. · Foods (Basel, Switzerland) · 2026
- 0.74
Hao F, Feng Y · Psychopharmacology · 2021
- 0.74
Xie S, Zheng B, Li M et al. · Food & function · 2026
- 0.74
Cui X, Wei Z, Wang Q et al. · Frontiers in pharmacology · 2026
- 0.74
Su Y, Wang D, Liu N et al. · PloS one · 2023
- 0.74
Huang Z, Gong Z, Lin Y et al. · Frontiers in aging neuroscience · 2024
- 0.74
Zhang S, Wei D, Lv S et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.74
Ma X, Shin YJ, Yoo JW et al. · Journal of advanced research · 2023
- 0.74
Arcos-Encarnacion B, Cortes-Flores E, Baron-Mendoza I et al. · Journal of neuroinflammation · 2025
- 0.74
Shen H, Jiang Y, Qiu C et al. · Journal of periodontal research · 2024
- 0.74
Yang Z, Zhang FR, Ren L et al. · Frontiers in pharmacology · 2025
- 0.74
Varinthra P, Ganesan K, Huang SP et al. · Frontiers in aging neuroscience · 2021
- 0.73
Ginseng and Polygonum multiflorum formula protects brain function in Alzheimer's disease
Liu JJ, Wei F, Wang YD et al. · Frontiers in pharmacology · 2025
- 0.73
Infantino R, Boccella S, Scuteri D et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
- 0.73
Su WS, Wu MT, Cheng IHJ et al. · Experimental neurology · 2025
- 0.73
Zhang W, Guo Y, Cheng Y et al. · International journal of biological macromolecules · 2023
- 0.73
Wang ZL, Pang SJ, Zhang KW et al. · Frontiers in nutrition · 2024
- 0.73
Kim Y, Cho M, Jeon CJ et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
- 0.73
Kang S, Lee J, Ali DN et al. · Scientific reports · 2024
- 0.73
Fluoxetine Repurposing Mitigates Alzheimer's Disease Pathology via the GSK3beta-CREB-ADAM10 Axis
Lee SH, Son Y, Jang H et al. · International journal of molecular sciences · 2026
- 0.73
Ye T, Yuan S, Kong Y et al. · Journal of agricultural and food chemistry · 2022
- 0.72
Bai P, Mondal P, Liu Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
- 0.72
Sola-Sevilla N, Garmendia-Berges M, Aleixo M et al. · Brain, behavior, and immunity · 2025
- 0.72
Ochi S, Yamada K, Saito T et al. · Frontiers in aging neuroscience · 2024
- 0.72
Effects of Chronic 100 mg/kg Cannabidiol Treatment in Male Double Transgenic APP(Swe)/PS1∆E9 Mice
Watt G, Olaya J, Muench G et al. · Pharmaceuticals (Basel, Switzerland) · 2026
- 0.72
Wu DD, Cheng J, Zheng YN et al. · Frontiers in cellular neuroscience · 2023
- 0.72
Rosell-Cardona C, Amat C, Grinan-Ferre C et al. · Nutrients · 2022
- 0.72
Torrecillas-Lopez M, Claro-Cala CM, Gonzalez-de la Rosa T et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
- 0.72
Yi S, Zou J, He X et al. · Research (Washington, D.C.) · 2026
- 0.72
Wei S, Ma X, Chen Y et al. · Molecular neurobiology · 2025
- 0.72
Li H, Xiao C, Wang F et al. · Foods (Basel, Switzerland) · 2023
- 0.72
The role of wheat embryo globulin nutrients in improving cognitive dysfunction in AD rats
Zheng S, Pan L, Hou J et al. · Food & function · 2022
- 0.71
Maekawa K, Sobue A, Komine O et al. · Scientific reports · 2025
- 0.71
Maftoon H, Davar Siadat S, Tarashi S et al. · Brain research · 2024
- 0.71
Braden-Kuhle PN, Lacy VA, Brice KN et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.71
Liu Q, Xie T, Xi Y et al. · Journal of agricultural and food chemistry · 2021
- 0.71
Li D, Li Y, Wen L et al. · Neuroscience bulletin · 2026
- 0.71
Lin J, Li J, Liang Z et al. · Ecotoxicology and environmental safety · 2025
- 0.71
Reducing brain Abeta burden ameliorates high-fat diet-induced fatty liver disease in APP/PS1 mice
Tsay HJ, Gan YL, Su YH et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
- 0.71
Bhuiyan P, Zhang W, Liang G et al. · Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
- 0.71
Richard JE, Mohammad A, Lieblich SE et al. · Biology of sex differences · 2026
- 0.71
Chesworth R, Gamage R, Ullah F et al. · Frontiers in neuroscience · 2021
- 0.71
Marizzoni M, Cattaneo A, Mirabelli P et al. · Journal of Alzheimer's disease : JAD · 2020
- 0.71
Zhang Y, Ding N, Hao X et al. · Frontiers in aging neuroscience · 2022
- 0.70
Mirzaei N, Mota BC, Birch AM et al. · British journal of pharmacology · 2021
- 0.70
Wang Y, Liu L, Zhang Y et al. · Scientific reports · 2026
- 0.70
Zhang C, Qi H, Jia D et al. · Life sciences · 2024
- 0.70
Liu J, Xie Y, Lu Y et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.70
Plasmon-activated water as a therapeutic strategy in Alzheimer's disease by altering gut microbiota
Cheng CH, Liu YC, Yang YCSH et al. · Aging · 2023
- 0.70
Zhang Y, Wang Y, Zhou Z et al. · Nutrients · 2024
- 0.70
Huuha AM, Norevik CS, Coombes JS et al. · Brain plasticity (Amsterdam, Netherlands) · 2024
- 0.70
Disturbance of REM sleep exacerbates microglial activation in APP/PS1 mice
Liu S, Meng Y, Wang N et al. · Neurobiology of learning and memory · 2023
- 0.70
Yang CC, Jia XY, Zhang L et al. · Chinese herbal medicines · 2020
- 0.70
Wu M, Chen YF, Yao W et al. · Scientific reports · 2025
- 0.70
Yi-Bin W, Xiang L, Bing Y et al. · Cell death & disease · 2022
- 0.70
Kwon YS, Ko JS, Oh SY et al. · International journal of molecular sciences · 2023
- 0.70
Bone marrow B lymphopoiesis accelerates early cerebral amyloid pathology
Zhang J, Fang W, Liu H et al. · Signal transduction and targeted therapy · 2025
- 0.69
Gao X, Sun H, Wei Y et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024
- 0.69
Son Y, Park HJ, Jeong YJ et al. · Neural regeneration research · 2023
- 0.69
Wang J, Zhou C, Huang Z et al. · Molecular neurobiology · 2025
- 0.69
Mei J, Shi X, Chen M et al. · Carbohydrate polymers · 2026
- 0.69
Park JS, Choe K, Ahmad R et al. · Brain, behavior, and immunity · 2025
- 0.69
Hao X, Ding N, Zhang Y et al. · Frontiers in neuroscience · 2022
- 0.69
Cui J, Xiao S, Cao Y et al. · Environmental science & technology · 2024
- 0.69
Chen L, Kang X, Deng W et al. · International journal of biological macromolecules · 2026
- 0.69
Casares N, Alfaro M, Cuadrado-Tejedor M et al. · Frontiers in immunology · 2023
- 0.69
Wang C, Shen D, Hu Y et al. · International journal of molecular sciences · 2023
- 0.69
Tranexamic Acid Improves Memory and Learning Abilities in Aging Mice
Hiramoto K, Yamate Y, Matsuda K et al. · Journal of experimental pharmacology · 2020
- 0.69
Wu S, Wu Q, Wang J et al. · Journal of agricultural and food chemistry · 2022
- 0.69
Munni YA, Tran KN, Jeon SM et al. · Frontiers in pharmacology · 2025
- 0.68
Canal C, Aguilar K, Comes G et al. · Alzheimer's research & therapy · 2026
- 0.68
Ginsenoside Rg2 Ameliorates Alzheimer's Disease by Alleviating Neuroinflammation in APP/PS1 Mice
Yeerkenbieke D, Guan Y, Cui J et al. · Current neuropharmacology · 2025
- 0.68
Xia N, Xu L, Huang M et al. · European journal of pharmacology · 2024
- 0.68
Progressive Hippocampal Neuroarchitecture Changes in the 5xFAD Alzheimer's Disease Mouse Model
Jang H, Lee S, Kim YJ et al. · Journal of integrative neuroscience · 2025
- 0.68
Kokhan VS, Levashova AI, Nesterov MS et al. · Biology · 2025
- 0.68
Soluble beta-amyloid impaired the GABA inhibition by mediating KCC2 in early APP/PS1 mice
Zhou Y, Cheng Y, Li Y et al. · Bioscience trends · 2021
- 0.68
Regular Physical Exercise Modulates Iron Homeostasis in the 5xFAD Mouse Model of Alzheimer's Disease
Belaya I, Kucharikova N, Gorova V et al. · International journal of molecular sciences · 2021
- 0.68
Zhong M, Xu QQ, Huang MQ et al. · Acta pharmacologica Sinica · 2025
- 0.68
Stallings NR, O'Neal MA, Hu J et al. · Alzheimer's research & therapy · 2023
- 0.67
Hassanzadeh G, Ashouri S, Kargar R et al. · Journal of molecular histology · 2025
- 0.67
Jiang X, Wu Q, Zhang C et al. · Neuro-degenerative diseases · 2021
- 0.67
Sasaki K, Becker J, Ong J et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
- 0.67
Modulation of Gut Microbiota and Neuroprotective Effect of a Yeast-Enriched Beer
Cecarini V, Gogoi O, Bonfili L et al. · Nutrients · 2022
- 0.67
Zhang S, Liu X, Xu S et al. · Biomolecules · 2025
- 0.67
Upadhyay P, Kumar S, Tyagi A et al. · BMC neuroscience · 2025
- 0.67
Ho A, Ngala B, Yamada C et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
- 0.66
Targeting MicroRNA-485-3p Blocks Alzheimer's Disease Progression
Koh HS, Lee S, Lee HJ et al. · International journal of molecular sciences · 2021
- 0.66
Lonnemann N, Hosseini S, Ohm M et al. · eLife · 2022
- 0.66
Zuo X, Kuang X, Zhao Y et al. · Molecular neurobiology · 2025
- 0.66
Ren D, Chai X, Xiang C et al. · Frontiers in nutrition · 2026
- 0.66
Wang L, Bi L, Qiu Y et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.66
Cheng L, Wang Y, Ma Y et al. · Food & function · 2026
- 0.66
Macheda T, Hawkins MR, Johnson CE et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
- 0.65
Palanivelu L, Chang CW, Li SJ et al. · ACS chemical neuroscience · 2025
- 0.65
Lee S, Lim CK, Kim J et al. · Biomedicines · 2025
- 0.65
Kim EH, Lee YJ, Moon YS et al. · Frontiers in aging neuroscience · 2025
- 0.65
Huang H, Lu W, Huang Y et al. · Journal of ethnopharmacology · 2026
- 0.64
Effects of ketogenic diet on cognitive functions of mice fed high-fat-high-cholesterol diet
Lin DT, Kao NJ, Cross TWL et al. · The Journal of nutritional biochemistry · 2022
- 0.64
Ding N, Hao X, Zhang Y et al. · Frontiers in neuroscience · 2025
- 0.64
Gu X, Zhou J, Zhou Y et al. · Alzheimer's research & therapy · 2021
- 0.64
Zheng Z, Chen C, Zhu S et al. · Experimental neurology · 2026
- 0.64
Sun H, Gao X, Niu J et al. · eNeuro · 2024
- 0.63
Liang J, Dong X, Yang J et al. · CNS neuroscience & therapeutics · 2025
- 0.63
Yang B, He M, Chen X et al. · Computational and mathematical methods in medicine · 2022
- 0.63
Yuan S, Lin L, Liu J et al. · Life sciences · 2026
- 0.63
Abdelhamid M, Zhou C, Ohno K et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.63
Effects of Qi-Fu-Yin on aging of APP/PS1 transgenic mice by regulating the intestinal microbiome
Xiao QY, Ye TY, Wang XL et al. · Frontiers in cellular and infection microbiology · 2022
- 0.63
Wei L, Yang X, Wang J et al. · Journal of neuroinflammation · 2023
- 0.63
A ketogenic diet improves memory in females in the APOE4 mouse model of Alzheimer's disease
Di Lucente J, Rutkowsky JM, Errico Provenzano A et al. · GeroScience · 2026
- 0.63
Banik A, Amaradhi R, Lee D et al. · Journal of neuroinflammation · 2021
- 0.62
Kozyrev N, Albers S, Yang J et al. · Journal of neuropathology and experimental neurology · 2020
- 0.62
Liu F, Duan M, Fu H et al. · Annals of surgery · 2022
- 0.62
Gavriel Y, Rabinovich-Nikitin I, Ezra A et al. · Journal of Alzheimer's disease : JAD · 2020
- 0.62
Belhaj I, Amellem I, Tartanoglu CH et al. · Scientific reports · 2026
- 0.62
Peck MR, Chapman JE, Hill T et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.62
Targeting Neuroinflammation and Apoptosis: Cardamonin's Cognitive Benefits in Alzheimer's 5XFAD Mice
Smail SW · Neurochemical research · 2024
- 0.62
Zhang YG, Li SY, Hu YZ et al. · Journal of neuroinflammation · 2026
- 0.60
Jarne-Ferrer J, Grinan-Ferre C, Jora B et al. · Aging and disease · 2025
- 0.60
Yu X, Xiao H, Bao S et al. · Journal of neuroinflammation · 2025
- 0.59
Liu Y, Li H, Wang X et al. · Journal of translational medicine · 2023
- 0.59
Pan JX, Sun D, Lee D et al. · Communications biology · 2021
- 0.59
Poffenberger CN, Taylor MM, Larson K et al. · Journal of neurotrauma · 2026
- 0.59
Martens N, Zhan N, Yam SC et al. · Nutrients · 2024
- 0.59
Fang C, Chen Q, Zheng G et al. · International journal of pharmaceutics · 2025
- 0.58
Astrocytes upregulate interleukin-15 in response to neuroinflammation during Alzheimer's disease
Shaw BC, Kaiser KE, Smith BC et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.58
Bae HJ, Kim SI, Kim SY et al. · Frontiers in microbiology · 2025
- 0.58
A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies
Yao Y, Kang SS, Xia Y et al. · Brain : a journal of neurology · 2021
- 0.57
Chen JD, Chen SY, Liao CC et al. · Food & function · 2025
- 0.57
Siripaopradit Y, Chatsirisakul O, Ariyapaisalkul T et al. · BMC neurology · 2024
- 0.57
Lee Y, Han S, Lee J et al. · Archives of pharmacal research · 2025
- 0.57
Fiala M, Hammock BD, Hwang SH et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.57
Galeano P, de Ceglia M, Mastrogiovanni M et al. · International journal of molecular sciences · 2023
- 0.57
Ramamoorthy K, Yoshimura R, Al-Juburi S et al. · Neurobiology of disease · 2022
- 0.57
Saieva S, Taglialatela G · Scientific reports · 2022
- 0.57
Du Y, Li X, An Y et al. · Frontiers in nutrition · 2022
- 0.56
Nie H, Wang X, Luo Y et al. · Journal of agricultural and food chemistry · 2024
- 0.56
Sheng Z, Xu F, Yan Y et al. · Frontiers in immunology · 2026
- 0.56
Ries M, Watts H, Mota BC et al. · Brain : a journal of neurology · 2021
- 0.55
Efficacy and Safety of a Brain-Penetrant Biologic TNF-alpha Inhibitor in Aged APP/PS1 Mice
Ou W, Ohno Y, Yang J et al. · Pharmaceutics · 2022
- 0.55
Alzheimer's disease/dementia-associated brain pathology in aging DPP6-KO mice
Lin L, Petralia RS, Holtzclaw L et al. · Neurobiology of disease · 2022
- 0.55
Zhang P, Song C, Shi J et al. · Molecular neurodegeneration · 2025
- 0.55
Lee D, Shen AM, Shah M et al. · International journal of molecular sciences · 2024
- 0.55
Analysis the alteration of systemic inflammation in old and young APP/PS1 mouse
Liu L, Cao J, Huang C et al. · Experimental gerontology · 2021
- 0.54
Chen YY, Chen SY, Lin JA et al. · Molecular nutrition & food research · 2023
- 0.54
Gupta DP, Lee YS, Choe Y et al. · Molecular brain · 2023
- 0.54
O'Niel A, Parkins CJ, Pederson A et al. · Frontiers in aging neuroscience · 2025
- 0.53
Lead-induced hypertension and cognitive dysfunction: brain amyloid pathology
Zhang Y, Xu Y, Song Y et al. · European journal of medical research · 2025
- 0.53
Lin K, Gu E, Ackerman S et al. · Cells · 2026
- 0.53
Al-Onaizi M, Al-Sarraf A, Braysh K et al. · The European journal of neuroscience · 2022
- 0.53
Mjaaseth UN, Hsu MF, Arballo J et al. · Frontiers in aging neuroscience · 2026
- 0.53
Surgical removal of visceral adipose tissue has therapeutic benefit in male APP(NL-F) mice
McFadden SA, Fang Y, Quinn K et al. · Frontiers in endocrinology · 2026
- 0.53
Lim JS, Kwak S, Yu MH et al. · Frontiers in aging neuroscience · 2025
- 0.52
Zhang T, Ruan J, Liu Z et al. · Brain, behavior, and immunity · 2025
- 0.52
Badr A, Daily KP, Eltobgy M et al. · Brain, behavior, and immunity · 2024
- 0.51
Marsland P, Vore AS, Lutzke A et al. · Brain, behavior, and immunity · 2025
- 0.51
Barnett A, David E, Rohlman A et al. · Frontiers in pharmacology · 2022
- 0.51
Qin C, Hu S, Zhang S et al. · Molecular nutrition & food research · 2021
- 0.50
Mygind L, Jensen G, Neesgaard V et al. · Brain, behavior, & immunity - health · 2025
04biomarkers · cerebrospinal fluid130편
- 0.94
Bernier RA, Banks SJ, Panizzon MS et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2022
- 0.93
Ghanbarian E, Khorsand B, Petersen KK et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.93
Quillen D, Hughes TM, Craft S et al. · Neurology(R) neuroimmunology & neuroinflammation · 2023
- 0.93
Caldwell JZK, Kinney JW, Ritter A et al. · Brain, behavior, and immunity · 2021
- 0.92
Zhang Y, Sun L, Zhao Y et al. · BMC medicine · 2026
- 0.92
Hoidy WH, Essa SM, Al-Saadi MH · The European journal of neuroscience · 2025
- 0.91
Azargoonjahromi A, Nasiri H · Journal of Alzheimer's disease reports · 2025
- 0.90
Ghanbarian E, Khorsand B, Petersen KK et al. · medRxiv : the preprint server for health sciences · 2024
- 0.90
Dharmapuri A, Chaudhuri S, Contreras JA et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.90
Plasma profiling of B lymphocyte-associated cytokines in Alzheimer's disease
Wang MT, Zhao RC, Huang M et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.90
Zhao A, Li Y, Deng Y · Neuroscience letters · 2020
- 0.90
Ng TKS, Beck T, Desai P et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2024
- 0.90
Brosseron F, Maass A, Kleineidam L et al. · Alzheimer's research & therapy · 2023
- 0.90
Serafini S, Ferretti G, Monterosso P et al. · Antioxidants (Basel, Switzerland) · 2024
- 0.89
Kellar D, Register T, Lockhart SN et al. · Scientific reports · 2022
- 0.89
Contreras JA, Aslanyan V, Albrecht DS et al. · Alzheimer's & dementia (Amsterdam, Netherlands) · 2022
- 0.89
de la Monte SM, Tong M, Hapel AJ · Biomedicines · 2023
- 0.89
Alruwaili M, Turkistani AA, Shilbayeh SAR et al. · Immunologic research · 2026
- 0.89
Sun W, Shan A, Wang P et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2026
- 0.88
Misiura MB, Joseph TO, Cooper JA et al. · Frontiers in dementia · 2026
- 0.88
Oberlin LE, Erickson KI, Mackey R et al. · Brain, behavior, and immunity · 2021
- 0.88
Inflammation, Cognition, and White Matter in Older Adults: An Examination by Race
Boots EA, Castellanos KJ, Zhan L et al. · Frontiers in aging neuroscience · 2020
- 0.88
Buhlin K, Eriksdotter M, Jansson L et al. · Journal of periodontology · 2026
- 0.87
Patterns of CSF Inflammatory Markers in Non-demented Older People: A Cluster Analysis
Peng Y, Chen B, Chi L et al. · Frontiers in aging neuroscience · 2020
- 0.87
- 0.87
Flores-Aguilar L, Iulita MF, Orciani C et al. · Journal of neuroinflammation · 2021
- 0.86
Wang Q, Yuan S, Wang C et al. · Alzheimer's research & therapy · 2024
- 0.86
Gonzalo R, Minguet C, Ortiz AM et al. · Annals of clinical and translational neurology · 2024
- 0.86
Arosio B, Rossi PD, Ferri E et al. · Experimental gerontology · 2025
- 0.86
Farahmand G, Leiby AMC, Yu J et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.85
Qin Q, Xia X, Qu J et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.85
CSF TNF alpha levels were associated with conversion from mild cognitive impairment to dementia
Fu P, Peng F · PloS one · 2022
- 0.85
Fu P, Zhu B, Huang Y · Neuropsychiatric disease and treatment · 2021
- 0.85
NFL strongly correlates with TNF-R1 in the plasma of AD patients, but not with cognitive decline
Delaby C, Julian A, Page G et al. · Scientific reports · 2021
- 0.85
Exploring molecular pathways in Alzheimer's disease neurodegeneration using biomarkers
Mondal A, Gupta S, Bhattacharjee A et al. · Bioinformation · 2026
- 0.84
Dabiri S, Ramirez Ruiz MI, Jean-Louis G et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
- 0.84
Plasma IL-6 Levels as a Biomarker for Behavioral Changes in Alzheimer's Disease
Yasuno F, Watanabe A, Kimura Y et al. · Neuroimmunomodulation · 2025
- 0.84
van Setten A, Uleman JF, Melis RJF et al. · GeroScience · 2025
- 0.84
Daniilidou M, Holleman J, Hagman G et al. · Translational psychiatry · 2024
- 0.84
de Assuncao Cortez Correa LC, Raffin J, Vellas B et al. · Maturitas · 2025
- 0.83
Gertje EC, Janelidze S, van Westen D et al. · Neurology · 2023
- 0.83
Higher CSF sTNFR1-related proteins associate with better prognosis in very early Alzheimer's disease
Hu WT, Ozturk T, Kollhoff A et al. · Nature communications · 2021
- 0.83
Clark C, Richiardi J, Marechal B et al. · Journal of neuroinflammation · 2022
- 0.83
Ye Z, Teng B, Wang S et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.83
Aiello AE, Momkus J, Stebbins RC et al. · Lancet regional health. Americas · 2025
- 0.82
Singh R, Rai S, Bharti PS et al. · BMC medicine · 2024
- 0.82
Sun Q, Ni J, Wei M et al. · Frontiers in aging neuroscience · 2022
- 0.82
Bruno M, Bonomi CG, Ricci F et al. · European journal of neurology · 2024
- 0.82
Nordengen K, Kirsebom BE, Richter G et al. · Journal of neuroinflammation · 2023
- 0.81
Salai KHT, Wu LY, Chong JR et al. · Biomolecules · 2023
- 0.81
Liakakis G, Vakrakou AG, Boufidou F et al. · Diagnostics (Basel, Switzerland) · 2025
- 0.81
Plasma osteopontin as a biomarker of Alzheimer's disease and vascular cognitive impairment
Chai YL, Chong JR, Raquib AR et al. · Scientific reports · 2021
- 0.80
Aljuhani M · Frontiers in aging neuroscience · 2025
- 0.79
Pillai JA, Khrestian M, Bena J et al. · Frontiers in aging neuroscience · 2021
- 0.79
Liu QF, Shi CN, Wu XM et al. · Translational psychiatry · 2026
- 0.79
Wharton W, Jeong L, Ni L et al. · Cerebral circulation - cognition and behavior · 2021
- 0.78
TNFRSF1B Gene Variants and Related Soluble TNFR2 Levels Impact Resilience in Alzheimer's Disease
Pillai JA, Bebek G, Khrestian M et al. · Frontiers in aging neuroscience · 2021
- 0.78
Jin H, He J, Zhang W et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.77
Seixas-Lima B, Rosa-Neto P, Phillips NA et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.77
Contreras JA, Ortega NE, Hayes CA et al. · Brain, behavior, & immunity - health · 2026
- 0.77
Nakamichi A, Kimura N, Hanaoka T et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.76
Capogna E, Watne LO, Sorensen O et al. · Brain, behavior, and immunity · 2023
- 0.76
Chua XY, Chai YL, Chew WS et al. · Alzheimer's research & therapy · 2020
- 0.76
Vilor-Tejedor N, Rodriguez-Fernandez B, Genius P et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
- 0.76
Aksnes M, Aass HCD, Tiiman A et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.76
Association between inflammatory biomarkers and cognitive aging
Fang Y, Doyle MF, Chen J et al. · PloS one · 2022
- 0.75
Phenotypic alterations in peripheral blood B Lymphocytes of patients with Alzheimer's Disease
Wang MT, Wang YR, Zeng GH et al. · The journal of prevention of Alzheimer's disease · 2025
- 0.75
Liu X, Yang B, Liu Q et al. · Scientific reports · 2025
- 0.75
Pan R, Luo S, Huang Q et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.75
Sexual dimorphisms in innate immune activation markers in predementia Alzheimer's disease
Knudtzon S, Nordengen K, Palhaugen L et al. · Brain communications · 2025
- 0.75
Inflammatory Biomarkers Aid in Diagnosis of Dementia
Erhardt EB, Adair JC, Knoefel JE et al. · Frontiers in aging neuroscience · 2021
- 0.74
Lawrence KA, Gloger EM, Pinheiro CN et al. · Brain, behavior, & immunity - health · 2024
- 0.73
Safety and efficacy of sargramostim (GM-CSF) in the treatment of Alzheimer's disease
Potter H, Woodcock JH, Boyd TD et al. · Alzheimer's & dementia (New York, N. Y.) · 2021
- 0.73
Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer's Disease Pathology
Riphagen JM, van Hooren RWE, Kenis G et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.73
Bachstetter AD, Lutshumba J, Winford E et al. · Brain communications · 2023
- 0.72
Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort
Foley KE, Winder Z, Sudduth TL et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.72
Licatini LM, Licatini LM, Haddadin FA et al. · Frontiers in neuroscience · 2026
- 0.72
Sadlon A, Takousis P, Ankli B et al. · Annals of neurology · 2024
- 0.72
Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer's disease
Aksnes M, Aass HCD, Tiiman A et al. · Translational neurodegeneration · 2021
- 0.72
Liu L, Gracely EJ, Zhao X et al. · Frontiers in aging neuroscience · 2024
- 0.72
Zuniga CH, Acosta BI, Menchaca R et al. · Alzheimer's research & therapy · 2025
- 0.71
Sun Z, Shen T, Li M et al. · Sleep & breathing = Schlaf & Atmung · 2026
- 0.71
Tofiq A, Zetterberg H, Blennow K et al. · Journal of Alzheimer's disease : JAD · 2021
- 0.71
Charisis S, Mourtzi N, Scott MR et al. · The journal of prevention of Alzheimer's disease · 2025
- 0.71
Cumplido-Mayoral I, Sanchez-Benavides G, Vilor-Tejedor N et al. · Molecular psychiatry · 2025
- 0.71
Asken BM, Tanner JA, Gaynor LS et al. · Alzheimer's research & therapy · 2023
- 0.71
Gonzales MM, Garbarino VR, Kautz T et al. · Research square · 2023
- 0.70
Van Hulle C, Jonaitis EM, Betthauser TJ et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
- 0.69
Gokce M, Velioglu HA, Bektay MY et al. · Gerontology · 2023
- 0.69
Pyo JH, Han SS, Kim MJ et al. · Biological psychiatry global open science · 2024
- 0.69
Ganesan VK · Current research in translational medicine · 2026
- 0.69
Sankhe K, Ruthirakuhan M, Andreazza AC et al. · International psychogeriatrics · 2026
- 0.68
Yang B, Teymur A, Tang C et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.67
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial
Gonzales MM, Garbarino VR, Kautz TF et al. · Nature medicine · 2023
- 0.67
Baril AA, Picard C, Labonte A et al. · Sleep · 2024
- 0.67
Chan HC, Ke LY, Lu HT et al. · Biomedicines · 2020
- 0.66
Lanzillotta S, Boccardi V, Zulli B et al. · Neurobiology of disease · 2026
- 0.66
Mallika AP, Sulajamani JP, Sivasankara MP et al. · Neurogenetics · 2025
- 0.66
Alvarez XA, Winston CN, Barlow JW et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.65
Olgun Y, Poyraz CA, Bozluolcay M et al. · Current Alzheimer research · 2024
- 0.65
Carvalho DZ, St Louis EK, Przybelski SA et al. · Frontiers in aging neuroscience · 2022
- 0.65
Dion C, Tanner JJ, Libon DJ et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.65
Tsai CL, Erickson KI, Sun HS et al. · Physiology & behavior · 2021
- 0.65
Rangel GA, Munoz BA, Ramirez M et al. · Journal of Alzheimer's disease reports · 2025
- 0.64
Lu WH, Guyonnet S, Martinez LO et al. · GeroScience · 2023
- 0.64
Mattar JM, Majchrzak M, Iannucci J et al. · International journal of molecular sciences · 2022
- 0.64
Low TGF-beta1 plasma levels are associated with cognitive decline in Down syndrome
Grasso M, Fidilio A, L'Episcopo F et al. · Frontiers in pharmacology · 2024
- 0.63
Shen H, Han C, Yang Y et al. · Brain and behavior · 2021
- 0.63
Associations of adverse childhood experiences, inflammation, and cognition in older Black adults
Rose DK, Drouin SM, Thibeadeaux D et al. · Psychoneuroendocrinology · 2025
- 0.63
Goikolea J, Gerenu G, Daniilidou M et al. · Alzheimer's research & therapy · 2022
- 0.62
Prenatal immune origins of brain aging differ by sex
Goldstein JM, Konishi K, Aroner S et al. · Molecular psychiatry · 2025
- 0.61
Tang J, Cao Z, Lei M et al. · Archives of gerontology and geriatrics · 2024
- 0.61
Zheng W, Zhou Y, Lu M et al. · Sleep medicine · 2026
- 0.61
Giudici KV, de Souto Barreto P, Guyonnet S et al. · The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
- 0.60
Feng V, Lanctot K, Herrmann N et al. · The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry · 2023
- 0.60
Sex differences in a murine model of Cerebral Amyloid Angiopathy
Maniskas ME, Mack AF, Morales-Scheihing D et al. · Brain, behavior, & immunity - health · 2021
- 0.60
Pak VM, Paul S, Swieboda D et al. · Alzheimer's & dementia (New York, N. Y.) · 2022
- 0.59
Sibilia F, Sheikh-Bahaei N, Mack WJ et al. · bioRxiv : the preprint server for biology · 2023
- 0.57
Lu WH, Gonzalez-Bautista E, Guyonnet S et al. · Journal of cachexia, sarcopenia and muscle · 2023
- 0.57
Barros-Aragao FGQ, Pinheiro TL, Pinto TP et al. · Brain, behavior, & immunity - health · 2025
- 0.56
Grasso M, Fidilio A, L'Episcopo F et al. · Neuromolecular medicine · 2026
- 0.55
Salvado G, Larsson V, Cody KA et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
- 0.54
Vacher M, Lee S, Price P et al. · BMC neurology · 2025
- 0.53
Saloner R, Casaletto KB, Rayaprolu S et al. · Molecular neurodegeneration · 2025
- 0.51
Wen CH, Kang HY, Chan JYH · International journal of molecular sciences · 2024
- 0.51
Hoyer-Kimura C, Palmer J, Gopalan R et al. · Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2025
- 0.51
Albrecht DS, Sagare A, Pachicano M et al. · Brain, behavior, and immunity · 2021
- 0.51
Shah HS, DeSalvo MN, Haidar A et al. · JCI insight · 2025
- 0.51
Zhang YJ, Cheng Y, Tang HL et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
- 0.50
Dabiri S, Mwendwa DT, Campbell A · Brain, behavior, and immunity · 2024
05mci · scores109편
- 0.94
Liu Y, Li Y, Zheng P et al. · Frontiers in neurology · 2026
- 0.94
Inflammatory Cytokines and Cognition in Alzheimer's Disease and Its Prodrome 이 논문
Seong SJ, Kim KW, Song JY et al. · Psychiatry investigation · 2024
- 0.91
Castro MM, Pavon RA, Moroni AD et al. · Medicina clinica · 2026
- 0.90
Wang W, Zhang J, Li C · International journal of psychiatry in medicine · 2025
- 0.90
Chen L, Qiu R, Wang B et al. · Food & function · 2024
- 0.90
Gonzalez-Bautista E, Soto M, Abellan van Kan G et al. · GeroScience · 2025
- 0.90
Desiato G, Bosco P, Cintoli S et al. · Brain, behavior, & immunity - health · 2025
- 0.90
Phoemsapthawee J, Ammawat W, Prasertsri P et al. · Journal of exercise rehabilitation · 2022
- 0.90
A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias
Haroon J, Jordan K, Mahdavi K et al. · Medicine · 2024
- 0.90
Vitamin D and inflammatory cytokines association in mild cognitive impaired subjects
Kumar A, Verma A, Chaurasia RN · Neuroscience letters · 2023
- 0.90
Koutentaki E, Basta M, Antypa D et al. · Healthcare (Basel, Switzerland) · 2023
- 0.90
Decreased Netrin-1 in Mild Cognitive Impairment and Alzheimer's Disease Patients
Ju T, Sun L, Fan Y et al. · Frontiers in aging neuroscience · 2021
- 0.89
Mahdavi M, Karima S, Rajaei S et al. · Galen medical journal · 2021
- 0.89
Relationship between cortisol, Interleukin-6 and homocysteine in Alzheimer's disease
Yeram N, Dalvi S, Mankeshwar R et al. · Qatar medical journal · 2021
- 0.89
Lu Y, Li J, Hu T · Computational and mathematical methods in medicine · 2022
- 0.89
Nie J, Fang Y, Chen Y et al. · Frontiers in immunology · 2021
- 0.89
Karima S, Aghamollaii V, Mahmoodi Baram S et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.88
Chen H, Liu S, Ge B et al. · The journal of prevention of Alzheimer's disease · 2021
- 0.88
Jin J, Lu L, Hua K et al. · Current Alzheimer research · 2024
- 0.88
Li Z, Wu H, Luo Y et al. · BMC neurology · 2023
- 0.88
Katsipis G, Tzekaki EE, Andreadou EG et al. · Neuroscience applied · 2024
- 0.88
A Mixed-Effects Model of Associations Between Interleukin-6 and Hippocampal Volume
Harrell ER, Bui C, Newman SD · The journals of gerontology. Series A, Biological sciences and medical sciences · 2022
- 0.88
Lewis JE, Reginald McDaniel H, Woolger JM et al. · Journal of Alzheimer's disease : JAD · 2023
- 0.88
Xin Y, Zhang L, Hu J et al. · American journal of translational research · 2021
- 0.88
Deng X, Zeng Y, Ding D · Pakistan journal of pharmaceutical sciences · 2026
- 0.87
Rashidi-Ranjbar N, Churchill NW, Jerkic M et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.87
Grasso M, L'Episcopo F, Fidilio A et al. · Frontiers in nutrition · 2026
- 0.87
Vasantharekha R, Priyanka HP, Nair RS et al. · Molecular neurobiology · 2024
- 0.87
Millar CL, Iloputaife I, Baldyga K et al. · EBioMedicine · 2025
- 0.86
Xu M, Yue Y, Huang J · Journal of pharmaceutical and biomedical analysis · 2023
- 0.86
Marr C, McDowell B, Holmes C et al. · Journal of Alzheimer's disease : JAD · 2024
- 0.86
Ochnik M, Zborowski J, Leszek J et al. · International journal of molecular sciences · 2025
- 0.85
Jing X, Wang L, Song M et al. · Scientific reports · 2024
- 0.85
Zhang W, Sun C, Huang Y et al. · Journal of diabetes and its complications · 2025
- 0.85
Yang Z, Zhang W, Liu D et al. · Frontiers in aging neuroscience · 2022
- 0.85
Schmidt-Morgenroth I, Michaud P, Gasparini F et al. · International journal of molecular sciences · 2023
- 0.85
Das SS, Gopal PM, Thomas JV et al. · Frontiers in dementia · 2023
- 0.85
Antequera D, Carrero L, Romualdi D et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
- 0.84
Vints WAJ, Gokce E, Seikinaite J et al. · European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity · 2024
- 0.84
Judd JM, Jasbi P, Winslow W et al. · Acta neuropathologica · 2023
- 0.84
do Rosario VA, Fitzgerald Z, Broyd S et al. · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2021
- 0.84
Wang T, Feng W, Ju M et al. · Journal of neuroinflammation · 2023
- 0.84
Clinical values of serum C5a in Alzheimer's disease patients with different dementia stages
Yang C, Wu X, Feng J et al. · Neuroscience letters · 2024
- 0.84
Lin PY, Cheng C, Satyanarayanan SK et al. · Brain, behavior, and immunity · 2022
- 0.83
Huang HH, Chang JCY, Liu HC et al. · Experimental gerontology · 2020
- 0.83
Alcala-Lozano R, Carmona-Hernandez R, Ocampo-Romero AG et al. · International journal of molecular sciences · 2025
- 0.83
Consumption of ultra-processed foods is associated with cognitive status in elderly patients
Grasso M, L'Episcopo F, Olvera-Moreira MA et al. · Frontiers in nutrition · 2026
- 0.82
Wang T, Zhao W, Liu Y et al. · Experimental gerontology · 2023
- 0.82
IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment
Toppi E, Sireno L, Lembo M et al. · Frontiers in immunology · 2022
- 0.82
Cai F, Xue S, Zhou Z et al. · The Science of the total environment · 2024
- 0.82
miR‑660‑5p ameliorates neuronal damage in Alzheimer's disease via targeting APP
Gong P, Su X, Fang Y · Neurogenetics · 2026
- 0.81
Giacconi R, D'Aquila P, Balietti M et al. · International journal of molecular sciences · 2022
- 0.81
Gabr SA, Salama ME, Alzahrani AH et al. · Scientific reports · 2026
- 0.81
Gorska-Ciebiada M, Ciebiada M · International journal of molecular sciences · 2024
- 0.81
The effects of dexmedetomidine on the cognitive function of mild cognitive impairment (MCI) rats
Zhou Q, Xie D, Chen T et al. · Annals of translational medicine · 2022
- 0.81
Qin Z, Han X, Ran J et al. · Neuroimmunomodulation · 2022
- 0.80
Zorkina Y, Abramova O, Ushakova V et al. · Women & health · 2023
- 0.80
Huang L, Zheng X, Zhang Y et al. · Annals of translational medicine · 2022
- 0.80
Romero-Sevilla R, Lopez-Espuela F, Fuentes JM et al. · Current Alzheimer research · 2022
- 0.79
The Role of Nutrition and Inflammation on Cognition in a High-Risk Group for Alzheimer's Disease
Jackson JM, Bay AA, Barter JD et al. · Journal of Alzheimer's disease reports · 2020
- 0.78
Grasso M, L'Episcopo F, Toscano G et al. · Antioxidants (Basel, Switzerland) · 2026
- 0.78
Chen Y, Du T, Lian T et al. · Frontiers in neurology · 2026
- 0.76
The Association between TNF-alpha, IL-1 alpha and IL-10 with Alzheimer's Disease
Culjak M, Perkovic MN, Uzun S et al. · Current Alzheimer research · 2020
- 0.75
Intelectin-1 and systemic inflammation indices as potential biomarkers in alzheimer's disease
Ozkaya AL, Gurbuzer N, Mercantepe F et al. · Metabolic brain disease · 2026
- 0.75
Pires LA, Almeida ALMd, Paraizo MdA et al. · Jornal brasileiro de nefrologia · 2022
- 0.75
Abuelezz NZ, Nasr FE, Abdel Aal WM et al. · Experimental gerontology · 2022
- 0.75
Xia J, Wu X, Wang Z et al. · Integrative medicine research · 2026
- 0.74
Farsi DN, Abadalkareem R, Linden GJ et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.74
MCP-1 levels in astrocyte-derived exosomes are changed in preclinical stage of Alzheimer's disease
Wang T, Yao Y, Han C et al. · Frontiers in neurology · 2023
- 0.74
Zhou H, Li S, Huang C et al. · Journal of integrative neuroscience · 2024
- 0.74
Alghadir AH, Gabr SA, Al-Momani M et al. · Cytokine · 2021
- 0.73
Shi J, Ni L, Yu S et al. · Frontiers in pharmacology · 2026
- 0.72
Wang M, Fang M, Zang W · Archives of gerontology and geriatrics · 2024
- 0.72
Ramadhani A, Tanaka A, Minagawa K et al. · European journal of dentistry · 2025
- 0.71
Sager R, Gaengler S, Willett WC et al. · The journal of nutrition, health & aging · 2024
- 0.71
Goodbody E, Maury J, Doolan A et al. · Frontiers in aging · 2025
- 0.70
Li C, Hao C, Zhou K et al. · Arthritis research & therapy · 2025
- 0.70
Teixeira AL, Salem H, Martins LB et al. · Journal of Alzheimer's disease : JAD · 2022
- 0.68
Kohn JN, Ang G, Pruitt C et al. · Biogerontology · 2025
- 0.68
Nianogo RA, Hays RD, Gong Y et al. · Journal of Alzheimer's disease : JAD · 2024
- 0.68
Basta M, Belogianni C, Yannakoulia M et al. · Healthcare (Basel, Switzerland) · 2022
- 0.68
Zhang H, Chen H, Pei H et al. · Evidence-based complementary and alternative medicine : eCAM · 2022
- 0.68
Probing gut-brain links in Alzheimer's disease with rifaximin
Suhocki PV, Ronald JS, Diehl AME et al. · Alzheimer's & dementia (New York, N. Y.) · 2022
- 0.66
Ha J, Kwon GE, Son Y et al. · Psychiatry and clinical neurosciences · 2024
- 0.65
Vints WAJ, Seikinaite J, Gokce E et al. · GeroScience · 2024
- 0.64
Medeiros EB, de Oliveira Monteiro I, Kluwe-Schiavon B et al. · Probiotics and antimicrobial proteins · 2026
- 0.64
Xin X, Chen J, Hua W et al. · International journal of geriatric psychiatry · 2021
- 0.62
Du J, An Z, Niu X et al. · Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology · 2026
- 0.61
Qian XH, Liu XL, Chen Sd et al. · Frontiers in immunology · 2022
- 0.61
Costantini E, Carrarini C, Borrelli P et al. · Immunity & ageing : I & A · 2023
- 0.61
Rahman MH, Bajgai J, Sharma S et al. · Antioxidants (Basel, Switzerland) · 2023
- 0.60
Duan M, Liu F, Fu H et al. · Frontiers in cellular and infection microbiology · 2021
- 0.60
Yu Y, Shen H, Qin Q et al. · Neuroscience · 2025
- 0.59
Ma C, Lin M, Gao J et al. · Aging clinical and experimental research · 2022
- 0.59
Yuan Q, He S, Elhassan MAM et al. · Journal of affective disorders · 2026
- 0.59
Du M, Wang X, Ma F et al. · Journal of cardiac surgery · 2022
- 0.59
Garrido-Dzib AG, Bravo-Armenta E, Rubio-Zapata H et al. · Psychoneuroendocrinology · 2026
- 0.58
Ho SK, Hsiao IT, Lin KJ et al. · Brain and behavior · 2024
- 0.58
Vacinova G, Vejrazkova D, Rusina R et al. · Neural regeneration research · 2021
- 0.57
Zhang H, Liang B, Chang Y et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.56
Neuropsychiatric Symptoms are Related to Blood-biomarkers in Major Neurocognitive Disorders
Marques-Aleixo I, Sampaio A, Bohn L et al. · Current aging science · 2024
- 0.56
Reduced Blood Choline in Obesity Is Associated with Metabolic and Alzheimer's Biomarkers
Winslow W, Judd JM, Tallino S et al. · Aging and disease · 2025
- 0.56
Lu Y, Jiang H, Zhang H et al. · Free radical biology & medicine · 2021
- 0.55
Smith PJ, Ingle KK, Nakamura Z et al. · Journal of Alzheimer's disease : JAD · 2026
- 0.55
Lee WJ, Shin YW, Kim DE et al. · Scientific reports · 2020
- 0.53
Valle VID, Mafla-Espana MA, Silva J et al. · Diseases (Basel, Switzerland) · 2023
- 0.53
Shateri S, Khatami SH, Haghbin Toutounchi A et al. · The International journal of neuroscience · 2025
- 0.52
Fiorillo A, Gallego JJ, Casanova-Ferrer F et al. · International journal of molecular sciences · 2023
- 0.50
Akalp K, Ferreira JP, Soares CM et al. · Archives of gerontology and geriatrics · 2024
06network pharmacology · molecular docking69편
- 0.88
Wang Z, Zhang HT, Li SY et al. · Computers in biology and medicine · 2025
- 0.88
Xu X, Zhao Y, Ma H et al. · International immunopharmacology · 2026
- 0.87
Liu S, Yan J, Dong J · Neurochemical research · 2026
- 0.86
Lei X, Xu H, Wang Y et al. · Drug design, development and therapy · 2023
- 0.86
Liang X, Ning T, Wang Y et al. · Frontiers in microbiology · 2026
- 0.85
Yu Q, Qiu X, Zhong J et al. · International journal of biological macromolecules · 2024
- 0.84
Xu Y, Zhang J, Li X · Frontiers in pharmacology · 2024
- 0.83
Wang Y, Liu C, Zheng X et al. · Frontiers in nutrition · 2025
- 0.83
Xiao S, Han Y, Yan J et al. · International immunopharmacology · 2026
- 0.83
He C, Yu W, Yang M et al. · Aging · 2023
- 0.82
Xiong L, Li Q, Zhou X et al. · Journal of Alzheimer's disease reports · 2025
- 0.82
Xi H, Xie W, Yang Y et al. · Drug design, development and therapy · 2025
- 0.82
Rakshit D, Nema M, Mishra A · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2026
- 0.82
Effect of Cerebralcare Granule(R) combined with memantine on Alzheimer's disease
Yang M, Zhang X, Qiao O et al. · Journal of ethnopharmacology · 2024
- 0.81
Cheng X, Dai Y, Shang B et al. · BMC complementary medicine and therapies · 2024
- 0.81
Zhu S, Li Y, Lin C et al. · Naunyn-Schmiedeberg's archives of pharmacology · 2026
- 0.81
Wang L, Lu Y, Liu J et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024
- 0.81
Pei H, He L, Shi M et al. · Aging · 2023
- 0.80
Hu D, Li D, He L et al. · Journal of ethnopharmacology · 2026
- 0.80
Sun T, Li Z, Xiao B et al. · Journal of ethnopharmacology · 2026
- 0.80
Mohamed Yusof NIS, Ramasamy K, Mohd Fauzi F · Neurochemical research · 2025
- 0.79
Wang J, Pan H, Tang H et al. · Journal of ethnopharmacology · 2025
- 0.79
Wang Y, Wu X, Yang K et al. · Frontiers in pharmacology · 2022
- 0.79
Yuan C, Lv S, Han Y et al. · ACS omega · 2025
- 0.78
Zhang X, Yang J, Xiao M et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- 0.78
Wang P, Dong YL, Li SS et al. · Journal of Alzheimer's disease : JAD · 2025
- 0.78
Lu H, Tan A, Zhang Y et al. · Journal of ethnopharmacology · 2024
- 0.78
Pang RK, Shi J, Peng XY et al. · Chinese medicine · 2025
- 0.78
Zhang X, Zhang SP, Li C et al. · Chinese journal of integrative medicine · 2026
- 0.78
Tong P, Li X, Li S et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- 0.77
Bian C, Wang W, Yao Z et al. · Ecotoxicology and environmental safety · 2026
- 0.76
Gao J, Song ML, Liu J et al. · Frontiers in medicine · 2026
- 0.75
Zhang Q, Gao M, Xu Z et al. · Metabolic brain disease · 2025
- 0.75
Liu W, Zhao Y, Liu T et al. · Frontiers in pharmacology · 2025
- 0.73
Pei H, Zeng J, Chen W et al. · Journal of biochemical and molecular toxicology · 2022
- 0.73
Miao J, Huang Y, Yi Q et al. · Food & function · 2025
- 0.73
Zhao T, Jia J · CNS neuroscience & therapeutics · 2024
- 0.72
Chen Y, Zhu Y, Tan Z et al. · Journal of ethnopharmacology · 2025
- 0.72
Tianma Formula Alleviates Dementia via ACER2-Mediated Sphingolipid Signaling Pathway Involving Abeta
Lin H, Wu S, Weng Z et al. · Evidence-based complementary and alternative medicine : eCAM · 2021
- 0.72
Tang C, Ding Y, Yang S et al. · Molecular neurobiology · 2025
- 0.71
Zhou S, Sun M, Song Z et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2025
- 0.71
Pan JZ, Yu MY, Tian MZ et al. · Experimental neurology · 2026
- 0.70
Ma W, Lu K, Liang HM et al. · Current Alzheimer research · 2023
- 0.70
Sheng F, Yu JM, Yang Q et al. · The Journal of pharmacy and pharmacology · 2026
- 0.70
Soni S, Sarkar S, Tripathi P et al. · Inflammopharmacology · 2026
- 0.68
Xu Y, Li N, Li X et al. · Journal of pharmaceutical and biomedical analysis · 2026
- 0.68
Zhou L, Yang C, Liu Z et al. · Journal of ethnopharmacology · 2024
- 0.67
Chang W, Chen Y, Kan J et al. · Food science & nutrition · 2026
- 0.66
- 0.65
Fu X, Huang J, Liu Y et al. · Frontiers in aging neuroscience · 2026
- 0.65
Fu G, Tang S, Sun X et al. · Frontiers in cell and developmental biology · 2026
- 0.65
Alzarea SI, Alsaidan OA, Qasim S et al. · Computers in biology and medicine · 2025
- 0.64
Mengnan L, Xianwen Y, Shuyan Z et al. · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023
- 0.64
Elucidating the Role of Trem2 in Lipid Metabolism and Neuroinflammation
Zhao C, Qi W, Lv X et al. · CNS neuroscience & therapeutics · 2025
- 0.64
Wang Z, Zhang Z, Shi J et al. · Molecular neurobiology · 2025
- 0.62
Xie Y, Fang C, Lu L et al. · Journal of ethnopharmacology · 2025
- 0.62
Xie M, Niu X, Shi L · Neuroscience · 2026
- 0.61
Liu XY, Wang K, Zhong JJ et al. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- 0.59
Xu W, Ren B, Zhang Z et al. · Frontiers in neuroscience · 2022
- 0.59
Lyu Y, Wang Y, Guo J et al. · Frontiers in aging neuroscience · 2023
- 0.58
Shen ZJ, Fu YB, Hou JL et al. · Chinese medicine · 2022
- 0.57
Pterostilbene targets microglia-mediated neuroinflammation for Alzheimer's therapy
Chen F, Lv X, Xiang K et al. · The Journal of nutritional biochemistry · 2026
- 0.57
Wang X, Fu X, Luo X et al. · Molecules (Basel, Switzerland) · 2023
- 0.55
Tang P, Zhao D, Lin H et al. · International immunopharmacology · 2025
- 0.54
Xie C, Tang H, Liu G et al. · Frontiers in aging neuroscience · 2022
- 0.54
Liu Y, Peng H, Liu Q et al. · Neuromolecular medicine · 2024
- 0.53
Gnanarajan R, Uvarajan D, Ravichandran N et al. · Progress in neuro-psychopharmacology & biological psychiatry · 2025
- 0.51
Wang F, Chen H, Hu Y et al. · Frontiers in pharmacology · 2022
- 0.51
Protective effect and mechanism of Zhuang medicine Tinosporae Radix on LPS-induced neuroinflammation
Wang J, Xie Y, Wang S et al. · Journal of ethnopharmacology · 2025
07review · neurodegenerative69편
- 0.84
Lopez-Rodriguez AB, Hennessy E, Murray CL et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2021
- 0.83
Hasantari I, Nicolas N, Alzieu P et al. · International journal of molecular sciences · 2024
- 0.82
Wahl D, Risen SJ, Osburn SC et al. · Journal of neuroinflammation · 2024
- 0.80
Shi Z, Cheng X, Zhang C et al. · International immunopharmacology · 2026
- 0.79
Diaz-Zuniga J, More J, Melgar-Rodriguez S et al. · Frontiers in immunology · 2020
- 0.79
Wu H, Qiu W, Zhu X et al. · Frontiers in aging neuroscience · 2022
- 0.78
Kim EH, Lee WS, Kwon DR · International journal of molecular sciences · 2024
- 0.78
Restoring regulatory T-cell dysfunction in Alzheimer's disease through ex vivo expansion
Faridar A, Thome AD, Zhao W et al. · Brain communications · 2020
- 0.77
Wang RPH, Huang J, Chan KWY et al. · Journal of neuroinflammation · 2023
- 0.76
Novel Anti-Neuroinflammatory Properties of a Thiosemicarbazone-Pyridylhydrazone Copper(II) Complex
Choo XY, McInnes LE, Grubman A et al. · International journal of molecular sciences · 2022
- 0.76
Madhu LN, Kodali M, Upadhya R et al. · Journal of extracellular vesicles · 2024
- 0.76
McGarry N, Murray CL, Garvey S et al. · bioRxiv : the preprint server for biology · 2021
- 0.75
Papait A, Natale F, Silini AR et al. · Translational neurodegeneration · 2026
- 0.75
Chu J, Hu H, Xu W et al. · Materials today. Bio · 2025
- 0.75
Wang L, Li B, Tang Z et al. · CNS neuroscience & therapeutics · 2025
- 0.74
Sai K, Nakanishi A, Scofield KM et al. · Journal of cell science · 2023
- 0.74
Zelek WM, Bevan RJ, Nimmo J et al. · Brain : a journal of neurology · 2025
- 0.73
Bai X, Wang B, Cui Y et al. · Journal of neuroinflammation · 2024
- 0.73
Lim JY, In Park S, Park SA et al. · Stem cell research & therapy · 2021
- 0.72
Alam JJ, Germann UA, Maruff P · Cells · 2026
- 0.72
Xu C, Mei Y, Yang R et al. · Cell & bioscience · 2024
- 0.70
Exploring the role of tocotrienol-rich fraction (TRF) in ameliorating neuroinflammation
Tan JY, Retinasamy T, Lee VLL et al. · Inflammopharmacology · 2026
- 0.70
Zhang P, Zhu Q, Zhang K et al. · BMC oral health · 2026
- 0.70
Wang Y, Zhang Y, Wang X et al. · Molecular nutrition & food research · 2023
- 0.69
Kang EY, Kim DY, Kim HK et al. · Molecular nutrition & food research · 2023
- 0.69
Nazli D, Poyraz YK, Can K et al. · Molecular neurobiology · 2026
- 0.69
De Sousa VL, Araujo SB, Antonio LM et al. · Brain, behavior, and immunity · 2021
- 0.69
Garcia C, Banerjee A, Montgomery C et al. · Frontiers in aging · 2025
- 0.68
Grinan-Ferre C, Jarne-Ferrer J, Bellver-Sanchis A et al. · International journal of molecular sciences · 2024
- 0.68
- 0.68
Panda SR, Soni U, Panja P et al. · ACS chemical neuroscience · 2026
- 0.67
Ren S, Breuillaud L, Yao W et al. · The Journal of biological chemistry · 2021
- 0.67
Sulimai N, Brown J, Lominadze D · Biomolecules · 2021
- 0.67
Ahmad S, Choe K, Badshah H et al. · Pharmaceuticals (Basel, Switzerland) · 2024
- 0.67
Sun C, Sha S, Shan Y et al. · International journal of nanomedicine · 2025
- 0.67
Wu L, Guo X, Gao Y et al. · International journal of biological macromolecules · 2024
- 0.66
Human neural stem cell-derived extracellular vesicles mitigate hallmarks of Alzheimer's disease
Apodaca LA, Baddour AAD, Garcia CJ et al. · Alzheimer's research & therapy · 2021
- 0.65
Malorny N, Chausse B, Khodaie B et al. · Journal of neuroinflammation · 2026
- 0.65
Akif A, Nguyen TTM, Liu L et al. · Fluids and barriers of the CNS · 2025
- 0.64
Akif A, My Nguyen TT, Liu L et al. · Research square · 2024
- 0.64
Increased cytokine gene expression and cognition risk associated with androgen deprivation therapy
Verma S, Kushwaha PP, Shankar E et al. · The Prostate · 2022
- 0.64
Jarne-Ferrer J, Grinan-Ferre C, Bellver-Sanchis A et al. · Pharmaceuticals (Basel, Switzerland) · 2022
- 0.63
IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer's disease
Brigas HC, Ribeiro M, Coelho JE et al. · Cell reports · 2021
- 0.63
McFall-Boegeman H, Talbot C, Montalbano M et al. · ACS omega · 2026
- 0.63
Althobaiti NA, Al-Abbas NS, Alsharif I et al. · Biochimica et biophysica acta. Molecular basis of disease · 2024
- 0.62
Espinosa-Garcia C, Srivastava U, Kumar P et al. · bioRxiv : the preprint server for biology · 2025
- 0.60
Lipid-conjugated siRNA targeting SARM1 enables CNS silencing and mitigates alzheimer-like phenotypes
Cai Y, Hou Q, Cheng Z et al. · Bioorganic chemistry · 2026
- 0.59
GRK5 Deficiency in the Hippocampus Leads to Cognitive Impairment via Abnormal Microglial Alterations
Shen H, Zhang T, Ji Y et al. · Molecular neurobiology · 2023
- 0.59
Sim AY, Kim JY, Lee YH et al. · Experimental neurology · 2025
- 0.58
Richards T, Perron JC, Patel K et al. · Research square · 2023
- 0.57
McGarry N, Murray CL, Garvey S et al. · Brain, behavior, and immunity · 2021
- 0.57
Jung H, Hyun G, Kim S et al. · Brain, behavior, and immunity · 2026
- 0.57
Gonullu S, Dalkilinc E, Celik O et al. · Neurotoxicity research · 2026
- 0.57
Rani A, Patra P, Verma TP et al. · ACS chemical neuroscience · 2024
- 0.55
KIT-13, a novel plasmalogen derivative, attenuates neuroinflammation and amplifies cognition
Hossain MS, Mawatari S, Honsho M et al. · Frontiers in cell and developmental biology · 2024
- 0.55
Beltran-Lobo P, Hughes MM, Troakes C et al. · Brain, behavior, and immunity · 2023
- 0.54
Rani V, Verma R, Kumar K et al. · Current research in pharmacology and drug discovery · 2023
- 0.54
Costachescu I, Gogu RM, Stanciu GD et al. · Frontiers in pharmacology · 2026
- 0.54
Salvadores N, Moreno-Gonzalez I, Gamez N et al. · Acta neuropathologica communications · 2022
- 0.53
Cholesterol 24-hydroxylase at the choroid plexus contributes to brain immune homeostasis
Tsitsou-Kampeli A, Suzzi S, Kenigsbuch M et al. · Cell reports. Medicine · 2023
- 0.53
Sharma S, Gilberto VS, Rask J et al. · ACS chemical neuroscience · 2024
- 0.53
Proteomic Signature and mRNA Expression in Hippocampus of SAMP8 and SAMR1 Mice during Aging
Reale M, Costantini E, Aielli L et al. · International journal of molecular sciences · 2022
- 0.53
Delta133p53alpha Protects Human Astrocytes from Amyloid-beta Induced Senescence and Neurotoxicity
Ungerleider K, Beck JA, Lissa D et al. · Neuroscience · 2022
- 0.53
Bernier F, Kuhara T, Xiao J · Microorganisms · 2023
- 0.52
Ramirez-Olvera A, Almazan JL, Perez-Martinez L et al. · Neurochemical research · 2026
- 0.52
Kays M, Kelly A, McGinnis F et al. · Frontiers in immunology · 2025
- 0.51
Espinosa-Garcia C, Srivastava U, Kumar P et al. · Molecular neurodegeneration advances · 2026
- 0.51
Schilling S, Chausse B, Dikmen HO et al. · Brain, behavior, and immunity · 2021
- 0.50
Thadathil N, Wolf NA, Wolf R et al. · Aging and disease · 2025
08activity · ache67편
- 0.86
Perez Gutierrez RM, Tellez Gomez J, Mota Flores JM et al. · Pharmaceuticals (Basel, Switzerland) · 2025
- 0.80
Lin Y, Lin X, Zhu J et al. · European journal of medicinal chemistry · 2026
- 0.80
Ullah R, Ali G, Subhan F et al. · International immunopharmacology · 2021
- 0.79
Tzekaki EE, Katsipis G, Chatzikostopoulos A et al. · Biology · 2025
- 0.79
Kaur A, Singh S, Singh M et al. · Experimental neurology · 2026
- 0.79
He J, Ran M, Tam KY · Brain research · 2025
- 0.78
M M, Kaliyaperumal R · Pharmaceutical nanotechnology · 2026
- 0.77
Anand A, Khurana N, Ali N et al. · Frontiers in neuroscience · 2022
- 0.77
Karami H, Soltani S, Wolber G et al. · BioImpacts : BI · 2025
- 0.77
Zhang X, Zhang X · Applied biochemistry and biotechnology · 2026
- 0.77
El-Nashar HAS, Abbas H, Zewail M et al. · Pharmaceuticals (Basel, Switzerland) · 2022
- 0.77
Halder T, Saha B, Dhas N et al. · Drug development research · 2024
- 0.77
Atef F, Abdelkawy MA, Eltanany BM et al. · Scientific reports · 2025
- 0.77
Hegazi NM, Mohamed TA, Salama A et al. · Food & function · 2024
- 0.76
Chiang KH, Cheng TJ, Kan WC et al. · Journal of ethnopharmacology · 2024
- 0.76
Cong S, Shi Y, Yu G et al. · European journal of medicinal chemistry · 2023
- 0.76
Ramachandran AK, Govindula A, Ranadive N et al. · European journal of pharmacology · 2025
- 0.76
Sa Y, Yuan H, Ma J et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
- 0.75
Ren M, Chen H, Li Z et al. · RSC medicinal chemistry · 2026
- 0.75
Chowdari Gurram P, Satarker S, Kumar G et al. · Journal of biomolecular structure & dynamics · 2023
- 0.75
Zhao X, Hu X, Xie Q et al. · Journal of ethnopharmacology · 2024
- 0.74
Uthaman SK, Kang WS, Park JY et al. · Heliyon · 2025
- 0.74
Zhou W, Chang Y, Xiao Q et al. · Bioorganic & medicinal chemistry · 2025
- 0.72
Pang L, Li J, Liu Z et al. · European journal of medicinal chemistry · 2022
- 0.71
Liu H, Zhang Z, Li X et al. · Food research international (Ottawa, Ont.) · 2025
- 0.69
Li Y, Hu C, Xia C et al. · Journal of nanobiotechnology · 2026
- 0.69
Prabakaran A, Rakshit D, Patel I et al. · International journal of pharmaceutics · 2025
- 0.68
Sang Z, Bai P, Ban Y et al. · Bioorganic chemistry · 2022
- 0.68
Elbermawy Y, El-Desouky S, Arafa RK et al. · Molecular neurobiology · 2025
- 0.67
Dong S, Xia J, Wang F et al. · European journal of medicinal chemistry · 2024
- 0.67
Herbet M, Wicha-Komsta K, Pawlowski K et al. · Behavioural brain research · 2026
- 0.67
Xiong Y, Zhou L, Zhang M et al. · Current neuropharmacology · 2025
- 0.67
Liu X, Xu J, Yu C et al. · Bioorganic chemistry · 2025
- 0.67
Yu H, Chen Y, Li H et al. · Bioorganic chemistry · 2025
- 0.67
Panda HS, Dhokne MD, Thakur S et al. · Small (Weinheim an der Bergstrasse, Germany) · 2025
- 0.67
Abdelrahman KS, Soltan OM, Abo Mansour HE et al. · European journal of medicinal chemistry · 2026
- 0.67
El-Desouky S, Abdel-Halim M, Fathalla RK et al. · Experimental neurology · 2025
- 0.66
Herbet M, Widelski J, Piatkowska-Chmiel I et al. · Journal of clinical medicine · 2022
- 0.66
Anwer R, Ullah I, Khan AU et al. · Inflammopharmacology · 2026
- 0.65
Gohar N, Abbas M, Masaud SM et al. · ACS omega · 2026
- 0.65
Jha AB, Chaube UJ, Jha AB · Heliyon · 2024
- 0.65
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy
Liu X, Xu J, Zheng S et al. · Pharmacological research · 2025
- 0.65
Liu D, Zhang H, Wang Y et al. · European journal of medicinal chemistry · 2022
- 0.65
Satpathy B, Rajwar TK, Mishra A et al. · Molecular neurobiology · 2025
- 0.65
Amelioration of cognition by hesperidin-conjugated cobalt oxide nanoparticles
Behera A, Satpathy B, Sahoo RK et al. · Scientific reports · 2024
- 0.64
Lin YW, Fang CH, Liang YJ et al. · International journal of molecular sciences · 2021
- 0.63
Kaboli Z, Hosseini MJ, Sadighian S et al. · International journal of pharmaceutics · 2023
- 0.63
Patel P, Faldu K, Borisa A et al. · Current neurovascular research · 2022
- 0.61
Xie Q, Hu X, Zhao X et al. · Journal of ethnopharmacology · 2024
- 0.60
Waiker DK, Verma A, Akhilesh et al. · ACS chemical neuroscience · 2023
- 0.60
Grinan-Ferre C, Jarne-Ferrer J, Bellver-Sanchis A et al. · CNS neuroscience & therapeutics · 2024
- 0.60
Sun Y, Xu L, Shao H et al. · Journal of medicinal chemistry · 2022
- 0.60
Carles A, Hoffmann M, Scheiner M et al. · CNS neuroscience & therapeutics · 2024
- 0.59
Liu T, Chen S, Du J et al. · European journal of medicinal chemistry · 2022
- 0.59
Ma R, Feng XY, Tang JJ et al. · Natural products and bioprospecting · 2024
- 0.58
Kandasamy K, Narasimhamoorthi SP, Arulselvan P et al. · 3 Biotech · 2026
- 0.57
Pozdnyakov DI, Zolotych DS, Rukovitsyna VM et al. · Iranian journal of basic medical sciences · 2022
- 0.57
Shankar G, Praveen Kumar C, Yadav M et al. · European journal of medicinal chemistry · 2024
- 0.57
Imran M, Shah FA, Nadeem H et al. · ACS chemical neuroscience · 2021
- 0.56
Pinky, Anwar S, Neha et al. · Brain research · 2025
- 0.56
Liu Y, Ma C, Li Y et al. · European journal of medicinal chemistry · 2024
- 0.56
Tu HJ, Su CJ, Peng CS et al. · Journal of food and drug analysis · 2023
- 0.55
Wang G, Du J, Ma J et al. · Pharmaceuticals (Basel, Switzerland) · 2023
- 0.54
The Tragedy of Alzheimer's Disease: Towards Better Management via Resveratrol-Loaded Oral Bilosomes
Abbas H, Gad HA, Khattab MA et al. · Pharmaceutics · 2021
- 0.52
Bansal R, Singh R, Rana P · Current computer-aided drug design · 2023
- 0.52
Cheng YG, Li JL, Li P et al. · Bioorganic chemistry · 2025
- 0.51
Kaur S, Bansal Y · Bioorganic chemistry · 2022